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2ABSTRACT
The neuropeptide Th1RFamide with the sequence Phe-Met-Arg-Phe-amide was originally
isolated in the clam Macrocallista nimbosa (price and Greenberg, 1977). Since its discovery, a
large family ofFl\1RFamide-related peptides termed FaRPs have been found to be present in all
major animal phyla with functions ranging from modulation of neuronal activity to alteration of
muscular contractions. However, little is known about the genetics encoding these peptides,
especially in invertebrates.
As FaRP-encoding genes have yet to be investigated in the invertebrate Malacostracean
subphylum, the isolation and characterization ofFaRP-encoding DNA and mRNA was pursued
in this project. The immediate aims of this thesis were: (1) to amplify mRNA sequences of
Procambarus clarkii using a degenerate oligonucleotide primer deduced from the common amino
acid sequence of isolated Procambarus FaRPS, (2) to determine if these amplification products
encode FaRP gene sequences, and (3) to create a selective cDNA library of sequences recognized
by the degenerate oligonucleotide primer. The polymerase chain reaction - rapid amplification of
cDNA ends (PCR-RACE) is a procedure in which a single gene-specific primer is used in
conjunction with a generalized 3' or 5' primer to amplify copies of the region between a single
point in the transcript and the 3' or 5' end of cDNA of interest (Frohman et aI., 1988). PCR-
RACE reactions were optimized with respect to primers used, buffer composition, cycle number,
nature ofgenetic substrate to be amplified, annealing, extension and denaturation temperatures
and times, and use of reamplification procedures. Amplification products were cloned into
plasmid vectors and recombinant products were isolated, as were the recombinant plaques formed
in the selective cDNA library. Labeled amplification products were hybridized to recombinant
3bacteriophage to determine ligated amplification product presence. When sequenced, the five
isolated PCR-RACE amplification products were determined not to possess FaRP-encoding
sequences. The 200bp, 450bp, and 1500bp sequences showed homology to the Caenorhabditis
elegans cosmid K09A11, which encodes for cytochrome P450; transfer-RNA; transposase; and
tRNA-Tyr, while the 500bp and 750bp sequences showed homology with the complete genome
of the Vaccinia virus. Under the employed amplification conditions the degenerate
oligonucleotide primer was observed to bind to and to amplify sequences with either 9 or 10bp
of 17bp identity.
The selective cDNA library was obselVed to be of extremely low titre. When library titre
was increased, white. plaques were isolated. Amplification analysis of eight isolated Agt11
sequences from these plaques indicated an absence of an insertion sequence.
The degenerate 17 base oligonucleotide primer synthesized from the common amino acid
sequence of isolated Procambarus FaRPs was thus determined to be non-specific in its binding
under the conditions required for its use, and to be insufficient for the isolation and identification
ofFaRP-encoding sequences. A more specific primer of longer sequence, lower degeneracy, and
higher melting temperature (TJ is recommended for further investigation into the FaRP-encoding
genes ofProcambarlls clarkii.
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INTRODUCTION
The neuropeptide FMRFamide (phe-Met-Arg-Phe-NH2) was originally identified in the
clam Macrocallista nimbosa (price and Greenberg, 1977). Immunoreactivity to FMRFamide-
specific antisera has since been reported in all major animal phyla, while several FMRFamide-
related peptides, or FaRPs, ~ have been isolated from arthropods (Trimmer et aI., 1987),
coelenterates (Grimmelikhuijzen and Grall, 1985) and chordates (Dockray et aI., 1983). FaRPs
are generally defined as any peptide that can be found by employing an assay for FMRFamide
(price and Greenberg, 1989). They have been observed to act as neurohormones,
neurotransmitters and neuromodulators in a wide range of tissues in various organisms, with
functions ranging from regulation of the cardiovascular system to enhancement of muscular
contractions, to modification of neuronal activity.
Recently, two newFaRPs known as DF2 (DRNFLRFamide) and NFl (NRNFLRFamide)
have been isolated from crayfish pericardial organs (Mercier et aI., 1993). These peptides were
found to be cardioexcitatory and to augment synaptic transmission at a neuromuscular synapse.
In some invertebrate organisms studied to date, single genes have been found to encode
for FMRFamide-related peptides (Linacre et aI., 1990), (Schaefer et aI., 1985). This is not the
case in Drosophila melanogaster, however, where a second gene coding for drosulfakinins,
peptides with structural similarity to FaRPs, has been isolated (as reviewed by Duve et aI., 1992),
and the presence ofa third gene encoding at least one FaRP has been postulated (Nichols, 1992).
In the invertebrate FaRP genes, encoded cleavage sites are of varying similarity between species,
and spacer sequences, which conform somewhat in length and frequency of occurrence, cannot
be said to have any clear function or ancestral form. The lack ofa representative FaRP gene from
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the Malacostracean subphylum limits our understanding of invertebrate FaRP genes and has
prevented the establishment of possible generalized invertebrate gene traits.
Recent investigations have determined length and abundance of invertebrate FaRP gene
transcripts. Invertebrate FaRP-encoding mRNA has been characterized for the fruit fly
Drosophila (Chin et aI., 1990), the sea slug Aplysia californica (Schaefer et aI., 1985), the
nematode Caenorhabditis elegans (Rosoffet al., 1992) and the snail Lymnaea stagnalis (Linacre
et al., 1990). In these studies, different length and abundance ofmRNA transcripts were found
in the different organisms. The findings ofboth Lehman et aI., (1984) and Schaefer et aI., (1985)
in Aplysia suggest that different mRNAs are transcribed in varying amounts according to the
tissue in which they are produced. As well, there is speculation that multiple RNA transcripts
may arise from a single gene by a number of mechanisms including alternate initiation site
recognition, alternate splicing and alternate polyadenylation, reflecting properties of the FaRP-
encoding gene itself
Determination of the genetic sequences coding for FaRPs in the Malacostracean
Procambaros clarkii would contribute much information to the knowledge of invertebrate FaRP
DNA and mRNA in general. Knowledge of the number ofProcambarus FaRP genes could aid
in the construction ofphylogenetic relationships between different invertebrate species and in the
establishment of genetic homology between individual peptides as well as between peptide
families. Such knowledge could also provide information regarding the possible existence and
structure ofone or more common FaRP precursor genes. Identification of transcription sites for
FaRP mRNA would contribute to the understanding of the means of communication by
neuropeptides in the organism, suggesting putative sites of action, pathways of neuropeptide
movement, and control mechanisms. In addition, the size, number and sites of transcription of
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FaRP-encoding RNA would all contribute to the characterization of the FaRPs within the crayfish
and provide much needed information concerning the genetic properties and phylogenetic
relationships ofFaRPs in invertebrates.
Genetic studies of crayfish FaRPs were investigated based upon the known amino acid
sequences ofthe two identified Procambarus FaRP sequences, NFb and DF2, as no portions of
FaRP gene sequences or adjacent sequences are known that could be used to locate Procambarus
FaRP gene sequences.
Thus, a common amino-acid sequence from the common NFLRF(Gly) portion ofNF1 and
DF2 was used to create a 16-fold degenerate 17-base oligonucleotide with binding capability to
the coding strand of NFl and DF2 -encoding DNA. This mixed oligonucleotide was used as a
primer in PCR amplification of FaRP sequences, as previous experiments using the common
gene-isolating technique of low stringency genomic library screening resulted in the isolation of
false positives when using this short oligonucleotide as a probe for FaRP sequences (Peaire,
1993).
The purposes of this study were three-fold. The first purpose was the optimization of
PCR-RACE reactions for th~ amplification of Procambarlls clarkii cDNA sequences with a
degenerate oligonucleotide primer designed to recognize the two sequenced ProcambartlS FaRPs.
This procedure involved selection and/or variation of primers used, of buffer composition, cycle
number, the nature ofthe genetic substrate to be amplified, annealing, extension, and denaturation
temperatures and times, and of the use ofre-amplification procedures. The second purpose of
the study was to determine if the amplification products encoded FaRP gene sequences.
Amplification products were cloned into plasmid vectors for easy amplification and isolation of
DNA sequences. Colony lift hybridizations were performed to determine if the cloned sequences
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were actual peR-RACE amplification products. Product sequences were also analyzed to
determine stringency of primer binding and for comparison with known sequences. The final
purpose ofthis study was to use the degenerate oligonucleotide to prime second strand double-
stranded cDNA (dscDNA) synthesis. These sequences were then ligated to l\gt11 vectors in an
attempt to create a selective cDNA.
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LITERATURE REVIEW
1.1 Neuropeptides
Neuropeptides are found in the nervous systems of all animals (Sherman et aI., 1989) as
well as in unicellular organisms (Scharrer, 1990). These peptides are produced by both neural
and non-neural tissues. It is well established that many neuropeptides are localized in nerve-cell
bodies and in nerve terminals (Kruk and Pyrock, 1979). In addition to being found in the central
nervous system (eNS), several neuroactive peptides are found in the non-neural cells of the
gastro-intestinal tract (Kruk and Pyrock, 1979).
The molecular diversity of neuropeptides is great, with as many as 100-200 different
peptide molecules serving as neuronal messengers in one animal species (Kandel, 1983), (Joosse,
1986).
In humans, there are at least 36 neuropeptides in the nervous system (Altman, 1989).
Overall, neuropeptides appear to be particularily important in regulating feelings and drives, such
as pain, pleasure, hunger, thir~t and sex (Alberts et aI., 1989).
1.1.1 Neuropeptide functions
N eurohormones, neurotransmitters, and neuromodulators have traditionally been
distinguished from each other'~ in regard to their sites of action, their duration of effect, and the
type of effect produced.
Neurotransmitters are classically defined as chemicals that travel across the synaptic cleft
from a neuron to another cell, which as a result of the arrival of the neurotransmitter, responds
by becoming either excited or inhibited with respect to a certain activity or process (Arms and
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Camp, 1989). Generally, neurotransmitters are low-molecular-weight molecules, synthesized by
nerve cells, that underlie a form of cell-cell interaction in the nervous system characterized as
synaptic transmission. They function over relatively small and discrete areas for brief periods
(milliseconds to seconds) (Barker, 1977).
Veca and Dreisbach (1988) state that in order for a compound to be classified as a true
neurotransmitter, four criteria must be met: (1) the substance must be synthesized by the neuron,
(2) it must be released by the neuron in sufficient amounts to exhibit an effect on another neuron
or effector organ, (3) exogenous application in appropriate quantities must mimic the action of
the endogenously released compound, and (4) a mechanism must exist to remove the
neurotransmitter from the site of action. Neurotransmitter effects at synapses that use channel-
linked receptors are immediate" simple, brief: and the transmitter released from one axon terminal
acts only on a single postsynaptic cell (Alberts et al., 1989).
In contrast to neurotransmitters, neuromodulators released from one axon terminal may
act on many cells in the neighborhood of that terminal, with the effects being slow, complex,
long-lasting, and often spatially~ diffitse. Neuromodulators work in many different ways, such as
by influencing the binding ofanother ligand at a specific site, or binding to a receptor whcih then
stimulates cAMP synthesis via a protein. These effects are positive or negative depending on
whether effector increases or decreases the protein's ligand-binding affinity (Voet and Voet,
1990).
Recent investigations have shown that neuromodulators play important roles in shaping
simple behaviors. They can act at many different sites within an animal in a coordinated fashion,
modulating the neural circuits for motor patterns in the central nervous system, altering
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motoneuron excitability, and modulating muscle response to motoneuron input (Harris-Warrick
et aI., 1989).
Neurohonnones can be, structurally similar or even identical to neurotransmitters. Unlike
neurotransmitters, however, they are released from sites near the circulation. They can act on
distant target sites, they can have long time courses of action (minutes to hours), and they can
exert multiple actions on a variety of nonneural and neural cellular elements. In addition,
neurohormones have greater potencies than neurotransmitters (Beltz, 1988). Neurohormones
are released from neurosecretory cells whose terminals end on the walls of vascular channels
(Scharrer, 1977). These neurohormones may act to change activity in central pattern-generating
circuits (Dickinson, 1989), in muscle fibres (Bishop et ai. 1987), in subsets of motoneurons
(Harris-Warwick and Kravitz, 1984), and in interneurons (Glanzman and Krasne, 1983) in such
a way as to promote a certain behavioral sequence or posture. Pasztor and MacMillan (1990)
have shown that individual modulators can have different effects at different sensory loci within
an organism, and that species specificity in neuromodulator actions exists even in closely related
species.
The distinctions between neurohormones, neuromodulators and neurotransmitters are
somewhat blurred. Current evidence shows that many peptides once regarded as conventional
neurohormones in both vertebrate and invertebrate systems are versatile compounds capable of
acting as transmitters in one area of the nervous system, as neurohormones in another, and as
neuromodulatory substances in yet another (Beltz, 1988). For example, somatostatin acts not
only as a neurohormone regulating pituitary function, but also as a neurotransmitter or
neuromodulator in brain sites outside the hypothalamus (ReicWin, 1981). Neuropeptides typically
have the following properties: low overall concentrations within organisms, high potency, marked
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specificity, and apparent low rate ofde novo synthesis in vitro (Reichelt and Edminson, 1977).
Extreme potency and targets activated by picomolar concentrations characterize those
neuropeptides with transmitterlike or hormonal effects. In certain regions of the central nervous
system, neuropeptides may be under feedback control in which systems for neuropeptide
breakdown are activated (Reichelt and Edminson, 1977).
In invertebrates, the behaviour ofneuropeptides differs from that of classical transmitters
(Voet and Voet, 1990). Joosse (1988) reports that unlike classical transmitters, no special
enzymatic machinery has been identified which effects the rapid breakdown of peptides at the sites
oftheir release, thus causing their actions to last longer than those of classical transmitters. As
well, peptides in the nervous ~ystem may diffuse to more widely distributed receptors (Kandel,
1983), and some neuropeptides are able to bind to several different receptors. Thus peptides can
potentially transmit more information than classical transmitters (Schwyzer 1980). Despite the
apparently greater amount of energy expended in synthesizing large neuropeptides as compared
to small classical transmitter molecules, these larger neuropeptides have persisted as messengers
throughout animal evolution. This observation may be explained by the finding that both their
large size and possession ofdirect genomic coding provide the potential for greater adaptational
and evolutionary control than that found in classical transmitters (Joosse, 1988).
When changes occur in amino acid composition due to DNA mutations, peptides have the
advantage over classical transmitters. The small size of classical transmitters increases the
possibility that any change in their structure will seriously affect the function, while a change in
the structure of large peptides may be gradual. This gradual change in structure makes peptide
messengers suitable candidates for a crucial role in the evolutionary development of regulatory
systems (Joosse, 1988). Small changes in molecular structure may alter the rate or duration of
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the process being controlled, an alteration which may provide a survival advantage for the
organism in which it occurs (Joosse, 1988). Neuropeptides are encoded by DNA, while the
structures ofthe synthesizing enzymes and not the classical transmitter itself are encoded within
the genome. Thus compared to neuropeptides, classical transmitters have the possible
disadvantage ofchanges in the genome affecting receptor binding, enzymatic breakdown and/or
reabsorption of the transmitter, any of which may prove lethal to the organism (Joosse, 1988).
Another positive aspect of the direct genomic coding of neuropeptide structure is the
occurrence of families ofgenes coding for the same neuropeptide precursor molecule, but with
slightly different molecular structures for the final product (as reviewed by Joosse, 1988). From
the viewpoint of population genetics this is a highly advantageous situation for the successful
control of adaptive changes.
1.1.2 Neuropeptide biosynthesis
What peptide or peptides are produced and secreted by a cell depends not only on the
particular mRNAs expressed in the cell but also on the production and distribution of the specific
enzymes involved in fashioning the final peptide product. Intracellular routing mechanisms also
act in this process by determining the fates of the newly synthesized peptides such as secretion,
degradation, and intracellular function (Loh and Gainer, 1983). There is also evidence supporting
external regulation of where neuropeptides may be produced. Recent findings suggest that
localized extracellular signals are capable of regulating the transcriptional states of nuclei;
resulting in synapse-specific g'ene expression (Burden, 1993).
Neuropeptides appear to be made by conventional peptide synthesis from amino acids
which are linked at ribosomes according to a sequence determined by an appropriate messenger
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RNA. Such synthesis appears to be confined to the cell body, since synthesis ofpeptides in nerve
terminals has not been observed and the cell body of a typical neuron contains high numbers of
ribosomes, some crowded togethor in the cytosol and others attached to the rough endoplasmic
reticulum. Although the dendrites of neurons often contain some ribosomes, no ribosomes are
present in the neuron axon (Alberts et aI., 1989). This cell body synthesis contrasts with the
synthesis ofestablished neurotransmitters, which can also be synthesized in nerve terminals (Kruk
and Pyrock, 1979).
A recent development supports the concept that glial elements also possess the ability to
synthesize neuropeptides. This idea is based on the demonstration that certain neuropeptide
genes are expressed in astrocytes. For example, the highest concentrations ofmRNA sequences
for the production of somastostatin and proenkephalins (as reviewed by Scharrer, 1990) have
been recorded in the hypothalamic astroglia (Scharrer, 1990).
Nonneural secretion of a neuropeptide has been demonstrated experimentally in Hydra
(Schaller, 1979). Normally, head activator hormone is produced primarily in nerves and stored
in neurosecretory granules. However, nerve-free Hydras were found to contain about 8 times
more head activator than did controls, with the hormone determined to be produced by
myoepithelial cells (as reviewed by 'Greenberg and Price, 1983).
In invertebrate nervous systems, there are neurons ressembling classical neurosecretory
cells which are specialized for peptide secretion. These cells contain many secretory granules
within the perikarya and an abundance ofrough endoplasmic reticulum. Although many of these
neurosecretory cells are endocrine cells, others have axons which extend into the central neuropile
where the neuropeptides are released (Golding and Pow, 1988).
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The hypothesis that all neurons, including those containing conventional transmitters, may
secrete peptides is supported by the finding of secretory granules in virtually all neurons (as
reviewed by Hokfelt et al., 1984). More than one neuropeptide can be produced and released by
the same neuron (as reviewed by Boer and Van Minnen, 1988). Both classical neurotransmitters
and neuropeptides have been· found in the same neuron. For example, in the snail Lymnaea
stagnalis, some neurons contain the classical transmitters serotonin and dopamine and at least one
vasotocin-like neuropeptide (as reviewed by Boer and Van Minnen, 1988).
Many neuropeptides can be found within the brain and other nervous tissues (as reviewed
"
by Hadley, 1988). Peptides originally considered to be gastrointestinal substances were later
shown to be present in brain tissue. For example, cholecystokinin (CCK) and substance P, first
isolated as gastrointestinal peptides, were subsequently localized in the mammalian brain (Hadley,
1988). The ability ofneurons, pituitary cells, or skin cells to produce a "peptide hormone", which
is able to act as a neuropeptide, is believed to be due to the fact that all of these cells are derived
from a "neuroendocrine-programmed" ectoblast. This concept attempts to provide an explanation
for the observation that substances commonly considered neuropeptides are found in the central
nervous system, the pituitary gland, .and such peripheral organs as the gastro-intestinal tract and
the skin (as reviewed by Hadley, 1988).
1.1.3 Neuropeptide precursors
All peptide neurotransrrtitters examined so far are synthesized first as a larger peptide, then
the active form of the molecule is produced through progressive cleavings by enzymes (Bloom,
1981). Neuropeptides are encoded as parts of high molecular weight precursors. These pro-
proteins are inactive fonns (Scharrer, 1990) which undergo posttranslational processing including
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sequential proteolytic cleavage by special converting enzymes and additional steps of modification
such as glycosidation, phosphorylation, acetylation, and amidation. As well, some precursor
molecules can give rise to different products depending on the site of synthesis (as reviewed by
Scharrer, 1990).
Much speculation exists concerning the role of the peptide precursor molecule. A
function that appears to be fulfilled by certain biosynthetic precursors is that of a prohormone that
provides a means to generate multiple biologic activities from a single gene product (Habener,
1981). Thus, one precursor is able to give rise to a host of fragments of widely differing
activities. Another role ofprecursors may be to ensure the correct formation of the secondary or
tertiary structure of a polypeptide following biosynthesis (Gainer, 1977). This precursor
formation is particularily useful in allowing proper formation of peptides composed of connecting
subunits encoded on the same"precursor molecule. Palade (1975) has also suggested that large
precursor molecules may be synthesized to prevent leakage of small peptide products through the
permeable rough endoplasmic reticulum membrane prior to its being packaged into a granule
membrane. Another postulated function ofthe peptide precursor is that of intracellular signalling,
\ .
by which cells can distinguish between differing classes of proteins and direct them to their
specific sites of action (Habener, 1981).
1.1.4 Neuropeptide sites of action
Neuropeptides may diffuse to more widely distributed receptors than classical transmitters
(Kandel, 1983), with certain peptides possessing the ability to bind to several different receptors
(Schwyzer, 1980). Neuropeptides bind with high-affinity and high specificity to receptor(s)
possessing saturable and reversible binding site(s) (Hadley, 1988).
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The sites of action of neuropeptides determines whether we classify them as
neuromodulators, neurohormones, or neurotransmitters. As neurotransmitters, neuropeptides
mediate signal transmission between neurons, between neurons and muscles, or between neurons
and glands (Voet and Voet, 1990). These transmitter molecules are released into the synaptic
cleft and then diffuse to the postsynaptic membrane, where they can bind to specific sites (Voet
and Voet, 1990). Peptide neurotransmitters use channel-linked receptors which, upon binding
neurotransmitter, change their conformation so as to create an open channel for specific ions to
cross the membrane, thus altering membrane permeability. Several transmitters may act
simultaneously, and the effect of a given substance depends on the context of all other
transmitters present. This principle has been demonstrated recently for three interacting
neuropeptides in the rat hypothalamus (Albers et al., 1991). Neuromodulators act upon the same
cells as do neurotransmitters, but are bound to different types of receptors. They possess non-
channel-linked receptors which work by being functionally coupled to an enzyme that in the
presence of neuromodulator catalyzes the production of an intracellular messenger. This
messenger then causes changes in the postsynaptic cell including modifications of ion channels
in its membrane (Alberts et aI., 1989). Neurohormones, once released, travel through the
circulation to a variety oftargets remote from neuron synapses and widely distributed throughout
the body.
1.2 FMRFamide related peptides (FaRPs)
The neuropeptide FNlRFamide, with the amino acid sequence Phe-Met-Arg-Phe-NH2 was
originally isolated from ganglia of the clam Macrocallista nimbosa by Price and Greenberg
(1977). Since this initial discovery, the distribution of FMRFamide-like peptides has been
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reported in all the major animal phyla. A number of FMRFamide-like peptides have been isolated
from coelenterates (Grimmelikhuijzen and Graff: 1985) arthropods (Boer et aI., 1980), and
chordates (Dockray et aI., 1983). Recently Fl\1RFamide-like immunoreactivity (FLI) has been
reported in the nervous system ofHydra (Bode, 1992).
Fl\1RFamide-related peptides (FaRPs) are generally defined as any peptide that can be
detected using an assay for Fl\1RFamide, and no requisite biological effects need to be involved
(price and Greenberg, 1989). More specifically, FaRPs are a heterogeneous assembly of peptides
which vary from 4 to 36 amino acids in length, having a penultimate arginine and a C-terminal
amide as their only common structural features (Price and Greenberg, 1989). Recently FaRPs
have been classified as a large neuropeptide group present in both vertebrates and invertebrates
(Boer et al., 1980; Greenberg and Price, 1983; Price and Greenberg, 1989). Among arthropods,
FaRPs have been detected in at least 6 insect species and 3 crustacean species (as reviewed by
Mercier et al., 1992). Studies ofvarious organisms have indicated that the N terminus of certain
FaRPs is crucial for at least some biological activities (Duve et aI., 1992).
In molluscs, FaRPs have been shown to comprise the peptides FLRFamide,
SPFLRFamide, and several heptapeptides with the general sequence XDFFLRFamide [where X
is GIu, GIy, Ser, or Asn] (as reviewed by Taghert and Schneider, 1990). In 1987, Trimmer et al.
isolated the peptides SDRNF~RFamide (termed F2) and TNRNFLRFamide (termed F 1) from
lobster tissue. Table I lists selected FaRP sequences which have been detected throughout the
phyla.
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TABLE!
Selected FaRP sequences throughout the phyla
Molluscs
Phe-Met-Arg-Phe-amide(price & Greenberg,1977) Macroca//ista
Phe-Leu-Arg-Phe-amide (Martin et aI., 1981) Octopus
Glu-Asp-Pro-Phe-Leu-Arg-Phe-amide (price et aI., 1990) Helix
Gly-Asp-Pro-Phe-Leu-Arg-Phe-amide (Ebberink et aI., 1987) Lymnaea
Ser-Asp-Pro-Phe-Leu-Arg-Phe-amide (Ebberink et aI., 1987) Lymnaea
Asn-Asp-Pro-Phe-Leu-Arg-Phe-amide (price et aI., 1990) Helix
Tyr-Gly-.Gly-Phe-Met-Arg-Phe-amide (Martin et aI., 1981) Octopus
Tyr-Gly-Gly-Phe-Met-Arg-Phe-amide (Nambu et a!.,1988) Drosophila
Asp-Pro-Lys-Gln-Asp-Phe-Met-Arg-Phe-amide (Sclmeider & Taghert, 1988)
Thr-Pro-Ala-Glu-Asp-Phe-Met-Arg-Phe-amide
Ser-Asp-Asn-Phe-Met-Arg-Phe-amide
Ser-Pro-Lys-Gln-Asp-Phe-Met-Arg-Phe-amide
Pro-Asp-Asn-Phe-Met-Arg-Phe-amide
Ala-Ala-Met-Asp-Arg-Tyr-amide
Met-Asp-Ser-Asn-Phe-He-Arg-Phe-amide
Ser-Ala-Pro-Gln-Asp-Phe-Val-Arg-Ser-amide
Crustacea
Ser-Asp-Arg-Asn-Phe-Leu-Arg-Phe-amide (Trimmer et al.,1987) Homarus
Thr-Asn-Arg-Asn-Phe-Leu-Arg-Phe-amide
Asp-Arg-Asn-Phe-Leu-Arg-Phe-amide (Mercier et aI.,1992) Procambarus
Asn-Arg-Asn-Phe-Leu-Arg-Phe-amide
Coelenterates
pGlu-Gly-Arg-Phe-amide (Grimmelkhuijzen & Graff,1986) Anthropleura
Vertebrates
Tyr-Gly-Gly-Met-Arg-Phe (Stem et aI.,1986) Bos
Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-amide
Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Gln-Arg-Phe-amide
Phe-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-amide (Yang et aI., 1985) Bos
Leu-Pro-Leu-Arg-Phe-amide (Dockray et a1.,1983)Gallus
Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Arg-Phe-amide (Williams, 1983) Rattus
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1.2.1 FaRP functions
In general, FaRPs are capable of acting as neurotransmitters, neuromodulators, or
hormones (Linacre et aI., 1990) as are most other neuropeptides. Specifically, physiological
studies have demonstrated that FaRPs have a variety of modulatory effects on both central and
peripheral targets (Schneider and Taghert, 1990). These peptides have been demonstrated to
decrease morphine-induced analgesia in mammals, (Yang et aI., 1985) and to increase the
amplitude and rate of induced muscle contractions in insects (Evans and Meyers, 1986).
FMRFamide itselfhas been found to possess anti-opiate properties in both molluscs and
mammals (Greenberg et aI., 1983) (Kavaliers and Hirst, 1985) (Raffa, 1988). In the sea hare
Aplysia, FMRFamide petforms multiple roles, functioning as a chemical messenger from neurons
to other neurons, to muscles, and to glands (Schaefer et aI., 1985). In this organism extensive
research has shown F:MRFamide to modulate the activity of specific central neurons, to cause
several kinds of membrane conductance changes in the eNS, and to shorten the presynaptic
action potential in sensory neurons. FMRFamide has also been shown to act in peripheral systems
by inhibiting spontaneous activity of the gut and salivary gland, and to stimulate contractions of
the buccal mass and gill (Linacre et al., 1990).
There are no general characteristics that can be assigned to the effects ofF:MRFamide or
its analogs. Results show that FaRPs exhibit multiple actions on various tissues, reflecting the
structural variation, not only ofthe peptides, but also oftheir receptors (Kobayashi and Muneoka,
1989). It is a common observation that a single FaRP may produce different effects at each of
its receptive tissues (Greenberg et aI., 1983).
There is evidence that FaRPs can function as both cardioregulatory hormones and
transmitters: FMRFamide-like immunoreactivity is present in Helix blood (Price et aI., 1985) as
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well as in the heart itself (Lehman and Price, 1987). Immunoreactivity in the locust nervous
system suggests that there is differential expression of FaRPs in different parts of the nervous
system, and bioactivity testing suggests that FaRPs in the locust function both as circulating
neurohonnones and as locally released neuromodulators or neurotransmitters (Robb and Evans,
1990).
Different FaRPs including those with close structural similarities have been observed to
elicit varying physiological responses. The tetrapeptide and heptapeptide FaRPs have distinct
effects on muscle tone and posture in pulmonate snails (as reviewed by Price and Greenberg,
1989), while FNlRFamide and FLRFamide modulate antagonistic gastropod buccal muscles
(Kobayashi and Muneoka, 1989). The modulatory effects of different FaRPs on heart activity in
invertebrates have been found to be dependent on the chemical structure of the peptide and on
the invertebrate species (Pai~ter and Greenberg, 1982). In invertebrate hearts, FaRPs elicit
responses that vary from being inhibitory to biphasic to excitatory (Mercier and Russenes, 1992;
Painter and Greenberg, 1982; Robb et aI. 1989; Kravitz et aI., 1987).
Observations that tetra- and hepta-FARPs have large differences in potencies and that in
some cases tetra-FaRPs produce opposing actions to the hepta-FaRPs (Cottrell and Davies, 1987),
(Lehman and Greenberg, 1987) have led to the suggestion that there is more than one type of
FaRP receptor in molluscan species (Cottrell et aI., 1992).
1.2.2 FaRP production sites and sites of action
FaRPs are known to be produced in the central nervous systems of invertebrates. Their
concentrations, however, are not uniform throughout constituent tissues, and the sites of action
ofFaRPs are diverse and vary between species.
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Several different tissues in invertebrates have been found to display FMRFamide-like
immunoreactivity (FLI). Such immunoreactivity often indicates the presence of either
FMRFamide or a molecule recognizing the RFamide sequence, but cannot identify the tissue in
question as either a FaRP production site or site of action (Duve and Thorpe, 1988). In the
marine molluscs Aplysia californica and Pleurobranchea california, FMRFamide
immunoreactivity was observed in the buccal ganglia, the cerebral ganglion, the abdominal
ganglion, and the pedal and pleural ganglia (Soinila and Mpitsos, 1991), while in octopus nervous
system a.1RFamide-like immunoreactivity was found in a neuropil layer of the vena cava (Martin
et aI., 1981).
1.2.3 Crayfish FaRPs
Immunoassays to determine the presence ofFaRPs in the crayfish Procambarus clarkii
(Mercier et aI., 1991) have shown FMRFamide-like immunoreactivity to be particularly
concentrated in the pericardial organs, which are known to release neurosecretory products that
modify cardiac and neuromu~cular functions. Immunoreactivity was also found in the second
thoracic roots and the connective tissue sheath surrounding the nerve cord (Mercier et aI., 1991).
The presence of FLI in cells associated with crayfish hindgut suggests that members of the
FMRFamide-related family of peptides may be involved in coordinating feeding and digestion in
arthropods (Mercier et aI., 1991). :Physiological experiments with isolated crayfish hearts and
hindguts support the notion that crayfish FaRPs are likely to play roles in controlling circulation
and defecation (Mercier et aI., 1991).
Two new FaRPs in the crayfish Procambarus clarkii have been extracted and sequenced
recently (Mercier et al., 1993). These peptides, structurally similar to the lobster peptides F1 and
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F:z, were named DF:z, which has the sequence DRNFLRFamide, and NFl' which has the sequence
NRNFLRFamide. NFl and Dij are cardioexcitatory and augment synaptic transmission at
neuromuscular synapses (Mercier et al., 1993; Skerrett et aI., 1995). Mercier et aI. (1992) report
that the peptides DF2 and NFl increased the rate and amplitude of spontaneous contractions in
semi-isolated crayfish hearts. Both of these peptides also increased the amplitude of excitatory
postsynaptic potentials recorded in phasic abdominal extensor muscles in response to nerve
stimulation. FNlRFamide-lik~ immunoreactive material from the crayfish hindgut appears to
contain at least one peptide distinct from NFl and DF2, based on elution on high performance
liquid chromatography (Mercier et aI., 1995). Partial sequencing analysis has shown this peptide
to have the sequence pEXXDHVFLRFamide (where "X" indicates an unidentified amino
acid)(Mercier et aI., 1995).
1.2.4 FaRP-encoding DNA
FaRP-encoding genes have been characterized in species representing all of the
invertebrate subphyla with the exception of Malacostraceans to which group the crayfish
Procambarlls clarkii belong. Aplysia californica and Lymnaea stagnalis (both molluscs),
Drosophila melanogaster and Drosphila virilus (members of the arthropod family), and the
annelid Caenorhabditis elegans have all been found to possess varying degrees of similarity in
their FaRP-encoding genes. In invertebrates studied to date, several different FNlRFamide-related
peptides have been encoded by the same gene, mRNA and protein precursors, with the occasional
occurance of multiple peptide copies (Linacre et aI., 1990). For example, the FNlRFamide
precursor gene ofAplysia encodes 28 copies ofFNlRFamide, one copy ofFLRFamide, and one
copy of a peptide ending in Tyr-Leu-Arg-Phe-amide. The available evidence indicates that
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several organisms, such as Lymnaea, Aplysia, and Caenorhabditis (Linacre et aI., 1990),
(Schaefer et al., 1985) (Rosoffet al., 1992) possess a single FaRP-encoding gene. However, the
existance of other genes containing small regions encoding peptides with sequences related to
FMRFamide cannot be excluded. In Aplysia a second neuropeptide gene expressed in the neuron
L5 encodes a peptide that ends with the sequence Arg-Phe-NH2 (as reviewed by Schneider and
Taghert, 1988), while either two genes encoding heptapeptide FaRPs occur in the snail Helix, or
a single gene encoding at ,least I five heptapeptides is present (price et aI., 1990). In
Caenorhabditis elegans, a single FaRP-encoding gene has been isolated (Rosoff et aI., 1992).
However, in the related nemotode Panagrelltls redivinus two new FaRPs not found on the C.
elegans FaRP gene (flp-1) have been discovered. As previously all Panagrellus FaRPs have
been found in C. elegans, it has be'en suggested that at least two different FaRP genes may be
present in nematodes (Maule et al., 1994). As well, the absence of methionine-containing FaRPs
in the flp-l gene ofC. elegans, coupled with HPLC analysis indicating a peak which coelutes with
authentic FMRFamide, suggests the presence ofa second FaRP gene in C. elegans (Rosoff et aI.,
1992). In Drosophila it has been found that there are at least two types of genes with the
potential for producing 10 or more FNlRFamide-related peptides. The Drosophila Fl\1RFamide
gene itself produces five distict FNlRFamides and three other peptides with variations in the
Fl\1RFamide C-terminal sequ,ence (Schneider and Taghert, 1988). The drosulfakinin gene,
encoding peptides homologous to both cholecystokinin and FNlRFamide gives rise to other
peptides ending C-terminally with -Met-Arg-Phe-NH2 (as reviewed by Duve et aI., 1992).
Recently, a new peptide with the sequence TDVDHVFLRFamide has been isolated from
Drosophila (Nichols, 1992). As neither the FNlRFamide or the drosulfakinin gene encode this
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peptide, it has been postulated that another gene encoding -Arg-Phe-NH2 peptides exists in this
organIsm.
The size and structure of Fl\1RFarnide-encoding genes has also been investigated in
invertebrates. In the fruit fly Drosophila melanogaster, the exons are 106 and 1352 base pairs
long, while in the related species Drosophila virilus, they are 169 and at least 1232 base pairs
long. The first exon of the Drosophila Fl\1RFamide gene consists of the 5' untranslated region
and is spliced to the initiator methionine codon. The second exon encodes the prohormone and
the 3' untranslated region of the mRNA. The promoter region contains a TATA box 30
nucleotides upstream from a consensus transcription start site (Chin et aI., 1990). In both species
the intron is approximately 2500 base pairs long (Taghert and Schneider, 1990). Lymnaea
stagnalis also possesses a single FaRP-encoding gene made up of 2 different exons. The first
exon encodes for FMRFamide, and is located 3.4kb 3' to the second GDP/SDPFLRFamide exon
(Saunders et aI., 1991). The Aplysia FaRP gene possesses at least 2 exons, but differs from
Drosophila and Lymnaea in th~t the precursor molecule is encoded by more than a single exon.
Finally, the flp-1 gene of C. elegans differs from the other invertebrate FaRP genes in that it has
six exons (Rosoff et aI., 1992). Three of the separating intrusions are < 85bp, one ofmediurn
length (156bp) and one relatively large (434bp).
In general, FaRP-encoding genes are composed of highly repetitive stretches containing
a FaRP sequence and its associated processing signals. In Aplysia many of these repeated
sequences are more than 90% identical at the nucleotide level (Price et aI., 1987b). In the FaRP
genes ofDrosophila, Aplysia, and Lymnaea, some FaRP sequences are not separated by spacer
regions, but instead are arranged in tandem pairs. Spacer regions separating FaRP sequences in
genes are generally short, but vary both within and between species. In Aplysia, spacers are
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usually composed of either seven or eight amino acids and are highly acidic, neutralizing the
positive charge of the basic peptide region. These spacers are less conserved than the peptide-
encoding regions (Taussig and Scheller, 1986). In Lymnaea, spacer regions, while still short, are
more variable in size and amino acid composition. Linacre et al. (1990) postulate that these
regions do not possess any biological function other than to separate FaRP sequences. This lack
of biological significance for spacers also seems probable in 3 other cases: (1) Drosophila
melanogaster, which possesses only one short spacer region between its 13 encoded FaRP
sequences (Schneider and Taghert, 1988), (2) the GDP/SDPFLRFamide exon ofLymnaea, in
which 15 encoded FaRP sequences are separated by only 2 amino acids used for amidation of
peptides and cleavage (Saunders et aI., 1991), and (3) in the flp-l gene ofC. elegans, in which
spacer regions are absent between most ofthe putative peptides, while those that are present are
not highly acidic and may represent peptides of unknown classes (Rosoff et aI., 1992).
Conversion of a precursor molecule into its final products occurs most frequently at adjacent
basic amino acid residues or at single arginyl residues (Wold, 1981; Loh et aI., 1984). Within the
invertebrates studied to date, some similarities in potential cleavage sites exists between
organisms. In the Aplysia Fl\1RFamide gene, nearly all of the Fl\1RF sequences are flanked on
the carboxy terminus by Gly-Lys residues, and on the amino terminus by Lys-Arg-, suggesting
that single basic lysine residues indicate cleavage sites to processing enzymes (Schaefer et aI.,
1985). The Fl\1RFamide exon of the Lymnaea stagnalis FaRP gene was also found to possess
similar cleavage recognition sites with the exception of a Lys-Ser residue on the amino terminus
ofone Fl\1RFamide (Linacre et aI., 1990). The GDP/SDPFLRFamide exon ofthe Lyml1aea FaRP
gene has both Gly-Lys residues, as found in Aplysia, and Gly-Arg residues (Saunders et aI.,
1991). These Gly-Arg and Lys-Ser residues ofthe Lymnaea FaRP exons are also common to the
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Drosophila FaRP gene which additionally contains Leu-Leu, Lys-Ser, Gly-Arg, Arg-Ser and Lys-
Lys cleavage sites (Schneider and Taghert, 1988). C. elegans also shows limited homology to
the other invertebrate cleavage sites, possessing either mono-, di-, or tribasic amino acids (Rosoff
et aI., 1992). Figure 1 shows schematic diagrams of the FaRP-encoding peptide precursors of
Drosophila and Lymnaea, representative of the similarities and diversities of the invertebrate
FaRP sequences characterized to date.
1.2.5 FaRP-encoding RNA
FaRP-encoding mRNAs have been characterized in selected invertebrate species. The
number of FaRP-encoding RNAs in different species has been a subject of controversy, with
different numbers ofRNA transcripts being reported for a single organism.
In the snail Lymnaea stagnalis isolation ofRNA and subsequent RNA blot hybridizations
have demonstrated the presence ofa single FaRP RNA transcript 1.7 kb in length (Linacre et aI.,
1990).
Attempts at identifying RNA transcripts ofFaRP genes in Drosophila have yielded some
conflicting results. Single RNA transcripts of approximately 1.7kb have also been reported in
other organisms, but these results coexist with other conflicting results. Schneider and Taghert
(1988) isolated two RNA transcripts from the fruit fly Drosophila melanogaster; one transcript
was 1.7kb in length and the other was approximately O.7kb in length. Subsequently, the same
researchers reported that when the RNA hybridizations were repeated using the same cDNA
probe but with its 3' untranslated end removed, hybridization to the smaller 0.7kb transcript did
not occur. It was suggested that this 0.7kb RNA represents an unrelated gene that has homology
to only the 3' untranslated end of the gene (Schneider and Taghert, 1990). However, the
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Figure 1:Schematic representations of the FMRFarnide polyprotein precursor in Lymnaea stagnalis (A) and in
Drosophila melanogaster(B), as adapted from Linacre et a!. (1990) and Schneider and Taghert (1988). These two
representative sequences demonstrate the multiple FaRPs commonly encoded on invertebrate FaRP precursors» the
widespread lack of spacer regions between encoded peptides, the occurance of short spacer sequences when present»
and the presence ofvarying numbers ofbasic residues between FaRP sequences. Deduced peptide cleavage products
are represented as boxes within the precursors. Stars indicate the presence and number ofbasic residues.
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Drosophila DSK gene encoding drosulfakinin peptides homologous to FMRFamide has been
found by Northern hybridization to possess a single mRNA transcript approximately 0.8kb long
(Nichols et aI., 1988). This related mRNA may account for the varying hybridization results of
Schneider and Taghert (1988, 1990).
In the sea slug Aplysia both the number ofFaRP RNA transcripts and their respective
sizes have been reported for neuron L5 (Shyamala et aI., 1986) and for neurons LI0, L12, and
L13 (Schaefer et aI., 1985). Shyamala et aI. (1986) report a single 1.8kb transcript expressed
mainly in the abdominal ganglion, and less intensely in the pleural ganglion, while Schaefer et aI.
(1985) described multiple RN:A transcnpts in many tissues. These latter findings included two
major RNA species of 1.4kb and 3.2kb and a less abundant transcript of more than 4.0 kb. The
smaller ofthe intense transcripts was predominantly expressed in the abdominal ganglion, while
the larger transcript was expressed in all ganglia examined. Less abundant RNA transcripts were
found principally in the pleural ganglia; all were smaller than the largest major transcript, while
some were less than 0.5kb in length. Although both of these studies used RNA hybridization as
their method of detection, the different radioactively-labelled cDNA clones used in the two
experiments were found to possess no substantial homology with each other (Schaefer et aI.,
1985).
The FaRP encoding gene ofLymnaea has been shown to undergo cell-specific alternative
RNA splicing. The two FaRP gene exons are spliced onto a common upstream exon encoding
a hydrophobic leader sequence, while in situ hybridization data shows that there is mutually
exclusive cytoplasmic expression of each of the neuropeptide-encoding exons. The observed
cellular specificity ofthe splicing events suggests that cell-specific alternative splicing may be an
important method of establishing neuronal diversity in this organism (Saunders et aI., 1992).
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The flp-1 gene ofCaenorhabditis elegw1S provided the first concrete example of a distinct
F:rvIRFamide-like peptide being derived from alternative splicing (Rosoff et aI., 1992). In this
organism, an alternative 3t splice acceptor site between exons 3 and 4 results in the substitution
of AGSDPNFLRFG for one of the copies of SADPNFLRFG found in the other translation
product, suggesting a unique role for the substituted peptide in the animal (Rosoff et aI., 1992).
Recent investigations of a similar FaRP-encoding gene in Caenorhabditis vztlgaris have also
demonstrated the production of two transcripts by alternative 3t splicing, suggesting functional
significance of the splicing procedure (Schinkmann and Li, 1994).
Observations of multiple FaRP mRNA transcripts have been linked to differences in
encoded peptides. For example, FaRP-containing neurons ofHelix aspersa appear to express
either the tetra-FaRPs or the hepta-FaRPs, but not both (Cottrell et aI., 1992). In these
experiments, mRNA transcripts were probed by molecular hybridization using cloned cDNA
probes, and FaRPs expressed by neurons were examined using radioimmunoassays (RIA) and
high performance liquid chromatography (HPLC). Analyses ofHelix cDNAs suggest that one
species ofmRNA encodes tetra-FaRPs, while another mRNA encodes all of the hepta-FaRPs and
the base sequence for one septa-FaRP.
1.2.6 FaRP-encoding protein precursors
Invertebrate FaRP precursors studied to date are similar in that they contain diverse yet
related neuropeptides, some ofwhich are present in multiple copies, while others are present in
single copies (Taghert and Schneider, 1990; Linacre et aI., 1990; Schaefer et aI., 1985). In the
snail Lymnaea stagnalis, a single gene was found to encode a precursor protein containing 9
copies of F11RFamide, 2 copies ofthe related peptide Phe-Leu-Arg-Phe-NH2 (FLRFamide), and
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a single copy of the putativ,e pentapeptides Gln-Phe-Tyr-Arg-Ile-NH2 (post translationally
modified to pQFYRIamide) and Glu-Phe-Leu-Arg-Ile-NH2 (EFLRIamide) (Linacre et aI., 1990).
The functional significance, ifany, of the 28:1 molar ratio ofF:MRFamide to FLRFamide found
in the Aplysia precursor protein is not clear (Taussig and Scheller, 1986); however the
resemblance to the mammalian enkephalin precursor, which contains seven copies of met-
enkephalin and a single copy ofLeu-enkephalin is striking (Comb et aI, 1982). F:MRFamide may
be less stable than FLRFamide due to the potential for oxidation of the thiol group on the
methionine side-chain. Alternatively, the two peptides may have different susceptibilities to
degradation by proteolytic enzymes or, as is the case with the enkephalins, the molecules may
have different affinities for surface receptors (Taussig and Scheller, 1986).
All secretory peptides, including the FaRPs, are encoded by their genes as a segment of
a larger precursor molecule. After translation, the secretory products are processed out of the
precursor by proteolytic enzymes (Greenberg and Thorndyke, 1989). The observation of
differential expression ofFaRPs in various tissues (Robb and Evans, 1990) suggests that different
FaRP-encoding precursors may be expressed differentially in various cell types or that the same
precursor is activated in all cell types, but its products are processed differently in different
tissues.
1.3 FaRP Similarities to Other Peptide Families
The family of F:MRFamide-related peptides displays striking but as yet unresolved
similarities with several other peptide families found throughout both vertebrates and
invertebrates. Assessment of actual homology between neuropeptide families occurs by
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reviewing structural similarities at all genetic levels, functional similarities, and distribution both
within an organism itself and throughout the animal kingdom.
Structural similarity characteristic of peptide families could arise in two ways: through
either duplication of the segment of a gene encoding a particular peptide and its processing
signals, or through duplication of the entire gene, followed by subsequent point mutation in one
ofthe duplicate sequences. Both ofthese processes will produce related peptides.Duplication of
peptide sequences is evident where very similar sequences are part of the same precursor. For
example, the 28 F11RFamide, and 1 FLRFamide sequences encoded in the Aplysia precursor
suggest duplication of a F11RFamide sequence with subsequent point mutation to change the
encoded Methionine to a Leucine sequence. Even where sequence similarity is low, the peptides
may have similar tertiary structures, suggesting divergence from a common genetic origin.
However, peptide families Of new members of existing families can also occur by chance,
particularly when the peptides are short. As peptides become shorter, the possibility that similar
sequences are convergent increases. If the precursor organization of a short peptide is not
known, convergence may not be detectable (price and Greenberg, 1989).
Sequence homology can be statistically evaluated according to the number of matching
amino acids within a given sequence. Price (1983) calculated that any given sequence of four
amino acids will occur at least once in the proteins of any species, but as the sequence increases
in length the odds of it occuring by chance decrease dramatically. Thus, matches of six amino
acids in a row are fairly unique and indicate a likely homology. The expression ofF11RFamide
actually requires a sequence of at least seven amino acids: Phe, Met, Arg, and Phe (the body of
the peptide); Gly (to form the amide); and at least one basic amino acid (eg. Arg)-but more
usually a dipeptide (Lys-Arg, Lys-Ser, or Arg-Ser) on each end as cleavage signals. On the basis
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ofthe above argument, a commonality of six residues (including processing signals) is assumed
to be the minimum requirement for homology (Price and Greenberg, 1989).
1.3. 1 The Cholecystokinin/Gastrin family
Cholecystokinin (CCK) is one ofa family ofpeptides, including the gastrins and caerulein
peptide, that is broadly distributed both phylogenetically and anatomically (Dockray, 1989). This
gastrin-CCK family is defined as consisting of peptides with the common C-terminal sequence
Gly-Trp-Met-Asp-Phe-NH2 which represents the biologically active portion of the molecule.
These peptides, found in both vertebrates and invertebrates, are thought to control several aspects
ofvertebrate gut function, and have been found to control feeding-related behaviour in mammals
(Dockray, 1989) and in the lobster (Turrigiano and Selverston, 1990). CCK-like peptides are
thought to function as neurotransmitters, neuromodulators, and neurohormones (Dockray, 1989).
CCK-like immunoreactivity has been found within the stomatogastric nervous system of
four species of decapod crustacea, including the crayfish Procambarus clarkii (Turrigiano and
Selverston, 1991). All four ·.species have CCK-like immunoreactivity within the pericardial
organs, thoracic segmental nerves, and in the haemolymph. The presence of detectable levels of
CCK-like peptide in these locations suggests that CCK-like peptides in decapod crustacea may
be utilized as neurohormones, while a neurotransmitter or neuromodulator role is also likely
(Turrigiano and Selverston, 1991).
In the crayfish, CCK may affect the amylase electrophoresis pattern (Denuce, 1982).
Gastrin and CCK stimulate the secretion of digestive enzymes in the gastric juice of crayfish (as
reviewed by Favrel et aI., 1987). A CCK-like peptide has been found to be present in the
stomatogastric nervous system of the lobster Panlilirlis inlerrupll./s and can be released into the
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stomatogastric ganglion (Turrigiano and Selverston). As well, the activity of the pyloric and
gastric mill can be modified by bath application of CCK. This strongly suggests that an
endogenous CCK-like peptide acts as a neuromodulator of the circuits in the stomatogastric
ganglion and thus plays a role in the control of gut function.
Several lines of evidence indicate the FaRPs and CCK-like peptides have homologous
distributions and functions. Such evidence includes the co-existence of CCK-like peptide and the
FaRPs in the pericardial orga~s of Procambarus (Turrigiano and Selverston, 1991; Mercier et
aI., 1992), related effects of CCK-like peptide upon the gastric mill in lobster (Turrigiano and
Selverston, 1989), and ofFaRPs in modulation of feeding in crayfish (Mercier et al.,1990), and
the effect ofboth CCK-like peptides and FaRPs upon invertebrate gut motility (Nachman et aI.,
1986; Mercier et aI., 1995) sU'ggests a homology in function and distribution.
Further evidence of relatedness between the FaRP and the CCKlgastrin peptide families
comes from studies characterizing the peptide leukosulfakinin. Leukosulfakinin (Glu-Gln-Phe-
Glu-Asp-Tyr(S03H)-Gly-His-Met-Arg-Phe-NH2) itself is a sulfated myotropic neuropeptide,
while the leukosulfakinins in general are a family of peptides possessing the C-terminus-
DYGHMRF-NH2 (Price and Greenberg, 1989). Leukosulfakinin (LSK) exhibits sequence
homology with the hormonally active portion of the vertebrate hormones human gastrin II and
CCK, suggesting that these peptides are evolutionarily related. Six of the eleven leukosulfakinin
amino acid residues are identical to those ofgastrin II. In addition, the intestinal myotropic action
ofleukosulfakinin is analogous to that ofgastrin, suggesting that it is unlikely that their structural
convergence is coincidental (Nachman et aI., 1986). Leukosulfakinins have also been found to
stimulate contraction ofthe cockroach hindgut (Holman et aI., 1986); a function similar to FaRP
modulation ofcrayfish hindgut (Mercier, et aI., 1995). These peptides demonstrate a structural
44
ressemblance to FMRFamide in their common terminal sequence Met-Arg-Phe-NH2 (Dockray,
1989).
Thus, leukosulfakinins, with similarities to both gastrins and FMRFamide may provide a
genetic link between the two peptide families which reinforces evidence of homology between
'I
the two families themselves. The sequence similarities which suggest a possible common
precursor link between the cholecystokinin /gastrin family and the FMRFamide-related peptides
are listed in Table II.
Another group of neuropeptides suggested to genetically link the FMRFamide and
CCK/gastrin families is that of the drosulfakinin peptides. These DSK peptides are homologous
to gastrin, CCK, and LSK sequences. That they share a similar C-terminal pentapeptide which
constitutes the CCK-gastrin bioactive site argues for a possible similarity in function (Nichols et
aI., 1988).
Genomic DNA and cDNA clones from Drosophila corresponding to the DSK precursor
encode three putative peptides. The three peptides (DSK-O, Asn-Gln-Lys-Thr-Met-Ser-Phe-Gly;
DSK-I, Phe-Asp-Asp-Tyr-Gly-His-Met-Arg-Phe-Gly; DSK-II, Gly-Gly-Asp-Asp-Gln-Phe-Asp-
Asp-Tyr-Gly-His-Met-Arg-Phe-Gly) are flanked by prohormone processing sites and contain C-
terminal glycocyl residues, a potential amidation site (Nichols et aI., 1988). Two of the peptides,
DSK-I and DSK-II, are homologous to CCK-gastrin peptides. Each of the two homologues
includes a CCK/gastrin-like C-terminal pentapeptide and a conserved sequence corresponding to
the sulfated tyrosine in bioactive CCK. Comparison of the amino acid sequences of the DSK
peptides with CCK reveals that four of the eight C-terrninal residues are identical. In addition,
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TABLE II
Sulfakinin-FMRFamide sequence similarities
Sequence similarities suggesting a possible conunon preCill'sor link bet\veen sulfakinins and FMRFamide related
peptides (as taken from Nichols et aI., (1988), Dockray (1989), De Loof and Schooes (1990) and Hadley (1992))
Cholecystokinin (Nichols et aI., 1988)
Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
Human gastrin I CDockray, 1989)
Lys-Ala-Pro-Ser-Gly-Arg-Val-Ser-Met-Ile-Lys -Asn-Leu-GIn-Ser-Leu-
Asp- Pro-Ser-His-Arg-Ile-Ser-Arg-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2
Drosulfakinin 0 (Nichols et aI., 1988)
Asn-Gln-Lys-Thr-Met-Ser-Phe-NH2
Drosulfakinin I (Nichols et aI., 1988)
Phe-Asp-Asp-Tyr-Gly-His-Met-Arg-Phe-NH2
Drosulfakinin II (Nichols et at., 1988)
Gly-Gly-Asp-Asp-Gln-Phe-Asp-Asp-Tyr-Gly-His-Met-Arg-Phe-NH2
Leucosulfakinin I (Nichols et aI., 1988)
G1u-GIn-Phe-G1u-Asp-Tyr-Gly-His-Met-Arg-Phe-NH2
Leucosulfakinin II (Nichols et aI., 1988)
pGlu-Ser-Asp-Asp-Tyr-Gly-His-Met-Arg-Phe-NH2
Drosophila peptide CDeLoof and Shooes, 1990)
Tyr-Gly-Gly-Phe-Met-Arg-Phe-NH2
Octopus peptide (Hadley, 1992)
Tyr-Gly-Gly-Phe-Met-Arg-Phe-NH2
FMRFamide CDeLoof and Schooes, 1990)
Phe-Met-Arg-Phe-NH2
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the DSK neuropeptides share many common amino acid sequences with FMRFamide-related
peptides, and so are presented as another possible link between the two peptide families.
1.3.2 Enkephalins
Finally, F1vIRFamide-related peptides are thought to be closely related to the enkephalins,
a family of pentapeptides which interact with opiate receptors and mediate analgesic responses
in mammals (Rosen et aI., 1984).
Met-enkephalin-Arg-Phe(YGGFMRF), at once an enkephalin and a FMRFamide analog,
was isolated from chromaffin cells of the adrenal medulla and in the striatum ofmammals (Stem
et al., 1979). It has been proposed that both FMRFamide and the enkephalins diverged from an
ancestral sequence, Tyr-Gly-Gly-Phe-Met-Arg-Phe-NHz, which acted at a single receptor having
a pair of binding sites, each complementary to one end of the peptide (Greenberg and Price,
1983). With time, two new types of bivalent receptors evolved; each type bound to both the N-
and C- terminals of the heptapeptide. Whereas the effective site for one type bound the C-
terminal as in present F~amide-like receptors, the other kind bound effectively to the N-
terminal, as do enkephalin-like receptors. Subsequent evolution presumably resulted in the
current groups ofF~amide-likeand enkephalin-like peptide and their respective receptors
with conserved message sequences at the C- and N- terminals respectively, and with varying
sequences at the opposite ends of the molecules (Greenberg et aI., 1986). The distribution of
enkephalin-like peptides and FaRPs in the animal kingdom is shown in Figure 2.
Research has supported this theory ofa F1vIRFamide-enkephalin linkage. Antisera against
the opioid peptide enkephalin and against the molluscan neuropeptide FMRFamide were observed
to immunostain identical nerve terminals and neurosecretory granules in a neuropil layer of the
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octopuS vena cav~. This coexistance of the two different immunoreactive indicates occurence
of a common enkephalin-Arg-Phe precursor (Martin et aI., 1981). In the octopus a naturally
occurring heptapeptide YGGF11RFamide was isolated from the vena cava neuropile (Martin et
ai, 1981) as well as from the brain, and was
found to possess both cardioexcitatory and opioid activity in octopus nerves (Voigt and Martin,
1986). This molecule contains both the F11RFamide sequence and the pentapeptide sequence
YGGFM of the opioid enkephalin (Brownstein, 1980) and, thus, may be responsible for the
coexistence ofenkephalin-like and F11RFamide-like immunoreactivity (Takayanagi and Takeda,
1988). Thus, this octopus peptide seems to provide the final link between the two peptide
families.
Homology between F11RFamide and opioid peptides has also been demonstrated at the
genetic level by Taussig and Sc.heller (1986). They showed that inAp[ysia californica, the gene
coding for the F11RFamide precursor molecule contains sequences coding for peptides related
to the opioid peptides.
1.3.3 Small Cardioactive Peptide b(SCPb)
In 1982, the small cardioactive peptide SCPb (Met-Asn-Tyr-Leu-Ala-Phe-Pro-Arg-Met-
NH2) was isolated from the opisthobranch gastropod, Aplysia (Morris et aI., 1982). With the
discovery of the sequence similarity between SCPb and F11RFamide, a new peptide family
including both peptides was suggested, and the proposed minimum structural requirement for
biological activity was Phe-a-Arg-b-NH2 (where a and b are hydrophobic amino acids). However,
SCPb has subsequently been found to be inactive on the Bllsycon radula protractor muscle and
on the Mercenaria heart, both classic F11RFamide bioassays (Price and Greenburg, 1980).
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Furthennore, SCPb did not react in a FMRFamide radioimmunoassay, and the two peptides were
demonstrated to have distinct distributions within the central ganglia ofAplysia (Lehman et aI.,
1984). In conclusion, the structural similarity between SCPb and F:MRFamide appears to be
fortuit9us as the distribution and activity of the two peptides are different (Lehman et aI., 1984)
and thus no homology was found to exist.
1.4 Aims of This Thesis
The general aims of this thesis were the isolation and characterization of the FaRP-
encoding gene or genes in the crayfish Procambarus clarkii. To this end, the objectives of this
thesis were threefold. The first was to optimize the amplification ofProcambarus eDNA using
degenerate oligonucleotide primers designed to recognize the two sequenced Procambarus
FaRPs. The second objective of this thesis was to determine the efficacy of these primers in the
characterization ofamplification products by sequencing reactions. Finally, the efficacy of these
degenerate oligonucleotides in their priming of second strand cDNA synthesis for insertion into
a selective cDNA library was studied. This study may provide a molecular basis for further FaRP
or crayfish investigations.
1.4.1 Crustacean investigations
Crustaceans have been useful in scientific investigations because of their small size, ease
of care and availability (Cooke and Sullivan, 1982). More importantly, their relatively small
neuronal complement allows individual behaviours to be studied at the neuronal level (Beltz and
Kravitz, 1986).
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1.4.2 FaRP investigations
FaRP investigations in general are of interest, as they serve to determine the range and
variety of FaRPs which exist, as well as indicating genetic relationships between species and
between neuropeptide families,. By inve.stigation of the FaRP-encoding genes and mRNA of an .
organism, infonnation is received concerning the genetic and functional structure of the organism
of interest.
1.4.3 Molecular investigations
Determination of the number of FaRP encoding genes, their characterization, and
investigation into the sites of this gene transcription often forms a basis for further research.
Since homology implies inheritance of common features from common ancestors,
detection of homology is best achieved by comparing the genes encoding the precursor
molecules. Thus, determination of the structure and organization of FaRP genes in various
organisms may reveal the relationship between different species. As well, such studies may
provide information with respect to the evolution ofFlvIRFamide and related peptides in other
organisms, reveal a time scale of origin of the FaRP peptides, or suggest the structure of a more
general FaRP precursor.
Determination ofthe structures ofDNA and mRNA also aids in the understanding of the
mechanisms and patterns of both evolution and regulation. For example, conserved regions
between different species in the putative promoter region are useful in defining DNA regions that
may regulate the expression ofthe gene and to determine such characteristics as whether the copy
number of the peptides within a precursor is critical for its functions, and the extent to which
slightly divergent peptide sequences mediate different peptide functions.
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Different methods of identifying and charcterizing a specific gene or segment of DNA
exist. In the search for FaRP-encoding genes, several of these methods have been employed.
Schneider and Taghert (1990) report that using a combination ofgenomic sequencing, Northern
blot analysis, and primer extensions, the organization and expression of the FaRP gene in
Drosophila was determined. cDNA synthesis, cloning and Maxam-Gilbert sequencing procedures
were also used in the characterization of FaRP genes in Lymnaea (Linacre et aI., 1990) and
Aplysia (Schaefer et aI., 1985).
1.5 Further Investigations
Characterization ofFaRP-encoding genes and RNA has previously been used towards the
long term goal of genetic analysis of neuropeptide expression and function (Schneider and
Taghert, 1988). Sequencing of the DNA and the mRNA are needed before a complete
explanation of the control of the expression ofFaRPs in this species can be obtained (Robb and
Evans, 1990). For example, by defining the transcription start site and promoter region of the
FNlRFamide gene, neuropeptide gene regulation can thus be studied.
The possibility of genetic manipulation in simple organisms does exist, and provides a
complemental)' means of studying neuropeptide function. By the possible disturbance of cellular
distribution of FaRP gene expression, alteration of the compositon of neuropeptides in their
precursor form, or by the abolishment of all FaRP expression, new insights into the roles of
neuropeptides on animal physiology, behaviour, and development could be gained. However, the
first step to these procedures is the isolation and examination of the FaRP-encoding gene or
genes.
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MATERIALS AND 11ETHODS
2.1 Animal Care
Crayfish Procambarus clarkii were obtained from Atchafalaya Biological Supply Co.
(Raceland, LA) and were kept at 15°C in aerated freshwater tanks and fed a mixed vegetable diet
prior to use. RNA was extracted from crayfish 3-5cm in length.
2.2 RNA Isolation
2.2.1 Crayfish dissection
Prior to dissection cr&yfish were cooled on ice for 20 minutes. During the dissection
gloves were worn to prevent possible contamination with RNAses, and instruments used in the
dissection were rinsed with O.5M EDTA.
Animals were humanely sacrificed by cutting and destroying the brain with scissors.
Animals then underwent dissectio"n to isolate suboesophageal and thoracic ganglia, abdominal
ganglia, deep abdominal flexor muscle, and heart.
2.2.2 RNA isolation procedure
RNA was isolated from tissue by means of the acid guanidium isothiocyanate-phenol-
chlorofonn extraction procedure ofChomczynski and Sacchi (1987). In this procedure tissue was
homogenized with ImL of denaturing solution (5M guanidium isothiocyanate, 25mM sodium
citrate, pH7, 0.5% sarcosyl, O.IM f3-mercaptoethanol). Guanidium isothiocyanate is a potent
denaturing agent which readily denatures proteins (Cox, 1968), resulting in disintegration of
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cellular structures and nucleoprotein dissociation from nucleic acids as the protein secondary
structure is lost.
In the procedure, RNA was separated from other cellular components by the addition of
acidic sodium acetate (which lowers the pH, rendering DNA insoluble in the aqueous phase),
phenol, (which disrupts the tertiary structure of proteins, resulting in protein aggregation), and
49: 1 chloroform:isoamyl alcohol (which permits further protein extraction, and also prevents
RNA from fractioning into th~phenol phase). Centrifugation at 10,000 x g was performed to
separate RNA in the aqueous phase from DNA and proteins in the interphase and phenol phase.
RNA was then isolated from solution by precipitation in 70% alcohol, purified by resuspension
in the denaturing solution and subsequent alcohol precipitation. The pellet was solubilized for
storage in 0.5% SDS, a detergent which weakly inhibits ribonuclease actions (Chomczynski and
Sacchi, 1987).
In this procedure and in all procedures involving the use ofRNA, all glassware, tubes, and
pipette tips were treated with diethyl pyrocarbonate (DEPC), which is a strong inhibitor of
RNAses (Fedorcsak and Ehronberg, 1966). Solutions used were made with 0.1% DEPC-treated
H20. Equipment was soaked overnight in a 0.1 % DEPC solution at 37°C, then autoclaved for
15 minutes to remove traces ofDEPC which might otherwise have modified purine residues in
RNA (Maniatis et aI., 1989).
2.2.3 Formaldehyde gel electrophoresis
RNA was separated according to size by means offormaldehyde gel electrophoresis. This
separation is possible because at pH 7, RNA is negatively charge and moves with a mobility
dependant upon the density ofthe agarose gel and upon its own fragment size. The formaldehyde
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gel was made up with 12.5mL formaldehyde, 7mL 10 x running buffer, and 0.56g agarose in
50.5mL DEPC-treated H20. This mixture with the exception offormaldehyde, was heated until
boiling, cooled to approximately 50°C, formaldehyde added, and poured into a casting tray with
the open ends taped and a well comb in place. After gel solidification, the tape and comb were
removed and the tray placed in an electrophoresis chamber with the well nearest the cathode.
550mL ofrunning buffer consisting of 55.0mL of 10 x running buffer, 391.8mL DEPC H20 and
103.2mL of37% formaldehyde was poured into the chamber, covering the gel. Formaldehyde
was present in both the gel and the running buffer due to its role as a hydrogen bond inhibitor
which permits the RNA to remain single-stranded. To each 10-2011L sample run on the gel, an
appropriate amount of5 x formaldehyde gel-loading buffer (80% formamide, 5% glycerol, ImM
EDTA pH 8.0,0.25% bromophenol blue, 0.25% xylene cyanol FF) was added. After loading the
gel, RNA fragments were separated by electrophoresis at 60V for approximately two hours.
2.2.4 Determination of concentration and purity of total RNA
The purity oftotal RNA was examined by denaturing agarose gel electrophoresis. In this
procedure RNA is separated according to size. Low molecular weight smears represent nucleic
acid degradation.
Whereas gel electrophoresis shows DNA contamination and nucleic acid degradation, UV
spectrophotometry permits nucleic acid quantitation and indicates if protein and phenol
contamination are present. RNA must be free ofDNA contamination in order to receive accurate
spectrophotometer quantitation, as DNA absorbs light at the same wavelength as does RNA.
In ultraviolet (UV) spectrophotmetry, l11L of RNA solution is mixed with 199111 of
DEPC-treated H20. Background absorbance for the sample is determined by scanning DEPC-
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treated H20 along a 240nm -320nm wavelength interval. The adjusted absorbance of the diluted
RNA sample is read along the same interval in optical density (O.D.) units. The concentration
ofRNA can then be determined using the equation 1 O.D.260 = 4011g/mL (Berger, 1987). RNA
purity is assessed by determination ofthe ratio of absorbance at 260nm/280nm. Values for RNA
solutions of 1.9 to 2.0 are acceptable. Lower values are usually indicative of phenol or protein
contamination (Berger, 1987). In order to render cuvettes RNAse-free, cuvettes are washed
briefly in 50mM NaOH, and then rinsed with DEPC-treated H20 (Promega technical bulletin).
2.2.5 mRNA isolation
Isolation of mRNA from total RNA was performed using the Poly ATtract mRNA
Isolation System (promega). This system uses a biotinylated oligo(dT) primer which hybridizes
to the 3' poly (A) region ofmRNA. Streptavidin coupled to paramagnetic particles is then added
to solution, binding to the biotinylated oligo(dT)-mRNA hybrids, and separating mRNA from the
total RNA in solution by magnetization of the paramagnetic particles. The solution is removed,
the paramagnetic particles are washed to remove any contaminating tRNA or rRNA, and the
purified mRNA is eluted from the solid particles by addition of ribonuclease-free deionized water,
which breaks existing hydrogen bonds between the mRNA poly (A) tail and the oligo(dT) primer.
2.2.6 Determination ofmRNA concentration and purity
UV spectrophotmetry can be used to determine mRNA concentration and purity in the
same manner as for total RNA.. However, when mRNA has been isolated from less than Img of
total RNA, absorbance must be read directly without sample dilution. 4011g/mL of mRNA has
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an absorbance of 1 at 260nm, while pure mRNA has an A26c!A280 absorbance ratio of 2 or more
(Promega).
2.3 cDNA Synthesis
2.3.1 First strand cDNA synthesis
First strand cDNA was synthesized from mRNA according to the procedure ofManiatis
et al. (1989). In this procedure, oligo(dT) binds to the poly(A) tail of mRNA, and reverse
transcriptase incorporates the appropriate dNTPs into the growing cDNA strand. RNasin is
present to prevent RNA degradation, while 2.5mM MgCl2 optimizes oligo(dT) primer binding
and enzyme activity (Innis, 1990). When working with single-stranded cDNA, it is essential that
all tubes and pipette tips used are siliconized using dichlorodimethylsilane to avoid sscDNA
adherance to these surfaces.
2.3.2 Second strand cDNA synthesis
Second strand cDNA for selected FaRP sequences was synthesized according to the
procedure of Maniatis et al. (1982). In this procedure the specific mixed oligonucleotide was
used to prime synthesis of selected second strands of cDNA with DNA polymerase. Second
strands were completed with reverse transcriptase (Maniatis et aI., 1982).
Mung Bean Nuclease was used to digest remaining single stranded DNA. Varying
amounts of Mung Bean Nuclease (OU, O.5U, IU, 2U) were used in reaction aliquots so as to
optimize the reaction; sufficient amounts of enzyme must be used so that maximal degradation
of single stranded DNA occurs, with minimal degradation of the double-stranded cDNA
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molecule. After the Mung Bean Nuclease reaction was performed, a subsequent fill-in reaction
was performed so as to render full-length any double-stranded cDNA molecules which may have
been somewhat degraded by excessive Mung Bean Nuclease activity (Maniatis et aI., 1982). The
resulting double-stranded cDNA was then methylated to protect internal restriction enzyme sites
(Maniatis et aI., 1982) and was ligated to radioactively phosphorylated linkers (Maniatis et al.,
1982), duplex molecules which are blunt at both ends and which possess specific restriction
enzyme sites which can be ligated to compatible termini in a vector, and so greatly increase
cloning efficiency (Wu et aI., 1987). Linker-dscDNA molecules were then digested with the
EcoR! restriction endonuclease in order to cleave duplex linkers and create cohesive ends.
Excess linkers, contaminating dNTPs, mRNAs and single stranded cDNAs were removed from
the linker-dscDNA molecules by product purification through A5M-columns. In this procedure,
samples are run through an A5M-column, and aliquots of column eflluent are taken. The
radioactivity in cpm units of these aliquots is taken and those samples which comprise part of a
single inital rise in radioactivity are taken and ethanol precipitation is performed on them. These
are the samples ofinterest as they contain the 32p-Iabelled linker-dscDNA molecules, and precede
the unincorporated 32p movement, observed as a final large increase in radioactivity, through the
A5M-column.
2.4 Polymerase Chain Reaction
The polymerase chain reaction (PCR) is a technique often used to overcome the
limitations of sequence analysis due to low product amounts or the presence of extraneous
material, by selectively amplifying of specific DNA sequences by a factor of 106 (Saiki et aI.,
1985; Mullis and Faloona, 1987). The peR procedure uses two oligonucleotide primers that
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flank the DNA segment to be amplified in continuing cycles of heat denaturation ofDNA strands,
annealing of primers to their complementary DNA strands, and extension of the primed DNA
strands. The oligonucleotide primers bind to opposite DNA strands, and are oriented such that
DNA synthesis proceeds across the region between the two primers, doubling the amount of
DNA ofinterest. Additionally, since the PCR products themselves are capable of binding to the
primers, each successive cycle ofpeR effectively doubles the amount ofDNA synthesized in the
previous cycle (as reviewed by Saiki et aI., 1988).
2.5 PeR-Rapid Amplification of cDNA ends (PCR-RACE)
Conventional PCR is limited in its use as it requires sequence information on both sides
of the region of interest. Thus, to permit amplification in which only a single short stretch of
sequence within an mRNA is known, Frohman et aI. (1988) introduced the PCR-rapid
amplification of eDNA ends (PCR-RACE) procedure. In this technique, cDNAs are generated
using the PCR technique to amplify copies of the region between a single point in the transcript
and the 3' or 5' end ofmRNA. For amplification of the mRNA 3' end, a single specific primer
which binds within the mRNA, and a general non-specific-type primer which binds to the 3' poly
(A) tail of the mRNA are used, as illustrated in Figure 3.
For this thesis, PCR-RACE amplification of the 3' ends ofmRNA was the method of
choice. No information exists as to the the nature of sequences within or flanking FaRP-encoding
gene or genes in the crayfish p'rocambarus clarkii. Thus, FaRP sequences were deduced from
the common NFLRF(Gly) sequence of the two known crayfish FaRPs, NFl and DF2, and the
codon bias found in the Drosophila FaRP gene (Schneider and Taghert, 1988; Akashi, 1994) was
employed to generate a 16-fold degenerate oligonucleotide primer 17 bases in length (see Table
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III). The non-specific primer chosen was the NOTI adaptor primer (Promega) due to low
annealing temperatures required with oligo(dT) use (Frohman et aI., 1988). The peR-RACE
procedure has some inherent disadvantages and difficulties which may be overcome by adjustment
ofreaction parameters. For some mRNAs, not all of the 3'end cDNAs generated are full length
(Frohman et aI., 1988). This problem can be overcome by either increasing extension time, or
if short strands are the result of dT primer binding to an A-rich region in the coding sequence
upstream ofthe poly (A) tail, then primer concentration can be decreased. (Frohman et aI., 1988).
It has also been observed that some of the PCR-RACE reaction products are single-stranded
cDNAs. This has been suggested to occur because use ofa gene-specific primer and a primer that
binds to every cDNA present may lead to greater production of one of the strands, or to
mismatched pairing of some strands after the final round ofPCR (Frohman et aI., 1988). This
problem can be overcome by al,tering buffer conditions. Due to cloning and amplification biases
in favour of short molecules, if more than one sequence is amplified then the shorter cDNA
species are overrepresented. Another problem inherent in the PCR-RACE procedure is the
occurrence of non-specific amplification, where sequences other than those of interest are
amplified due to primer redundancy or mismatches (Frohman et aI., 1988). In order to optimize
PCR reactions, some adjustments can be made to some ofthe reaction parameters. These include
alteration ofreaction buffer composition, particularly MgC1 2 concentraton, adjustment of primer
concentration, dNTP concentration, enzyme concentration, enzyme choice, annealing time and
temperature, and extension time and temperature (Saiki, 1989).
2.5.1 Specific primer selection
As neither positions of the FaRP-encoding gene(s) in Procambarzls, nor adjacent
sequences are known, the selection of a specific primer for the PCR-RACE reaction was made
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TABLE III
Degenerate oligonucleotide primer sequences
Amino acid sequence of degenerate oligonucleotide primers coding for the amino acid sequence NFLRF(G) used as
specific 5' end primer in PCR-RACE 3' end amplification, and as primers for the synthesis of second strands of cDNA
in the construction of a selective cDNA library.
NFL R F G
1. AAT TIC AAG AGG TTC GG
2. AAT TTC AAG AGA TTC GG
3. AAT TTC AAG AGT TTC GG
4. AAT TTC AAG AGC TTC GG
5. AAT TTC AAG CGG TIC GG
6. AAT TTC AAG CGA TTC GG
7. AAT TTC AAG CGT TTC GG
8. AAT TTC AAG CGC TTC GG
9. AAC TTC AAG AGG TTC GG
10. AAC TTC AAG AGA TTC GG
11. AAC TTC AAG AGT TTC GG
12. AAC TTC AAG AGC TTC GG
13. AAC TTC AAG CGG TTC GG
14. AAC TTC AAG CGA TTC GG
15. AAC TTC AAG CGT TTC GG
16. AAC TTC AAG CGC TTC GG
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from the common known amino acid sequence of the endogenous Procambarus FaRPs NFl and
DF2• Although these peptides possess a common RNFLRFamide sequence, the oligonucleotide
sequence was based upon the NFLRFamide sequence so as to reduce both cost and primer
degeneracy, and so as not to preclude primer binding to other possible FaRP sequences. The
specific primer synthesized was, as according to the directives of Cooper and Isola (1993) "a
"specific" deoxyoliogonucleotide of limited degeneracy that represents the most likely codon
combinations following reverse translation of a previously determined C-terminal amino
sequence". The codon usage was assumed to be that found in the Drosophila FaRP gene
(Schneider and Taghert, 1988). As suggested, the specific primer utilizes only the most prevalent
codons ofan amino acid, uses a singular 3' most codon or partial codon, and does not exceed 16-
fold degeneracy. (Cooper and Isola, 1993). As in this case the final amino acid is Glycine
(subsequently cleaved to form the NH2 group) which has a GGX (where X represents T,C,A or
G) codon usage, only the initial GG sequence was used in the degenerate primer. This partial
codon usage follows the directives of Cooper and Isola (1993) which state that in primer design
"terminating one nucleotide from the most highly degenerate third is a great help, ensuring that
the last two nucleotides are homologous". Cooper and Isola (1993) also suggest designing of
primers such that the amino acid sequence is encoded by the lowest possible number of codons
from available protein sequence information. As the Arginine (R) residue is encoded by eight
possible codons with similar fr~quencies of occurence, the N terminal arginine was omitted from
the primer sequence; reducing primer degeneracy from 128-fold to 16-fold. This use of a
restricted number ofcodons is an effective means of controlling the loss of amplification product
specificity characteristic of degenerate probes (Cooper and Isola, 1993), while peR is generally
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assumed to be acceptably efficient when using primers with 15-20% bp mismatches with the
template (Rychlik, 1993).
2.5.2 Determination of oligonucleotide concentrations
The concentration of dissolved oligonucleotide primers was measured by means ofUV
spectrophotometry. These oligonucleotides, which absorb ultraviolet wavelengths between
250nm and 270nm due to the spectral characteristics of their four composite bases, have specific
molar extinction coefficients for these bases which allow oligonucleotide concentrations to be
determined. The molar extinction coefficients of oligonucleotides differ from those of longer
DNA molecules due to the "hypochromic effect" in the DNA, in which the intensity of absorption
is reduced due to the interaction between absorbing units placed in an orderly array (Berger,
1987).
In the detennination ofoligonucleotide concentration, the molar extinction coefficient for
the particular sequence must be calculated, as outlined by Wallace and Miyada, (1987). This
value is found by summing the contribution of each base. The molar extinction coefficients at
260nm for the bases are: G, 12,010; A, 15,200; T, 8400; and C, 7050. The concentration ofa
solution ofthe oligonucleotide can then be determined by measurement of the absorbance of the
solution at 260nm.
2.5.3 Annealing temperature selection
In the selection of a gene-specific primer for the amplification of cDNA 3' ends, the
calculated melting temperature (TnJ of a perfect hybrid is determined. However, when using a
pool of oligonucleotides which differ greatly in their G+C composition as the gene-specific
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prImer, it is impossible to determine a representative Tm' Since it is unknown which
oligonucleotide sequence will perfectly match the genomic sequence of interest, conditions must
be used that allow that oligonucleotide with the lowest G+C content to anneal efficiently.
Optimal annealing temperatures are generally 2-4°C less than the predicted Tm of the most AfT
rich member of the oligonucleotide pool (as reviewed by Maniatis et aI., 1989). The Tm of the
most NT rich oligonucleotide is calculated by means of the equation:
(# of residues of A+T)2°C + (# of residues ofG+C)4°C = Tm
Thus, for the sequence AAT TTC AAG AGT TTC GG, the most NT rich oligonucleotide, the
Tm is: (11)2°C + (6) 4°C = 46°C.
The annealing temperature, chosen to be 2°C less than the Tm of the most NT rich
member of the oligonucleotide pool is 44°C. Maniatis et al (1989) note, however, that the use
of such "lowest common denominator" conditions can lead to false positives being received due
to mismatched oligonucleotides of greater G+C content possibly being more stable than a
perfectly matched hybrid formed by the correct oligonucleotide.
2.5.4 Selection of generalized 3' end mRNA primer
In the selection of an adaptor primer for amplification of cDNA 3' end, it must be noted
that although long stretches of residues anneal perfectly to the poly (A) tail of mRNA, they do
not base pair well at the temperatures used to prevent mismatches of the specific primers
(Frohman et al., 1988). The calculated Tm of oligo(dT)17 is: (17)2°C = 34°C, 12°C below the Tm
ofthe most AfT rich member ofthe gene-specific oligonucleotide pool primer. Thus, the NOT1
adaptor primer with the sequence 5'-d[AATTCGCGGCCGCTTTTTTTTTTTTTTT]-3' and a Tm
of 74°C is used. Use of this primer allows annealing temperature to be optimized according to
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the requirements ofthe gene-specific oligonucleotide pool primer. As Rychlik (1993) states "the
optimal annealing temperature range is unusually broad when primers exhibiting low 3'-terminal
stability (as evidenced by high T occurrence) are used. Thus, the NOT1 primer, with a long 3'
poly(T) sequence, should not experience annealing problems at the much lower temperatures
conducive to the degenerate oligonucleotide primers.
The NOT1 primer was chosen as it possessed the qualities desired in an adaptor
oligonucleotide: "a closely ma~ched G+C content, ... and a lack of sequence homology with the
unique oligonucleotide" (Cooper and Isola, 1993), as well as a specific restriction endonuclease
site which aids in detection of specific cDNA clones (Kuehl and Battey, 1993).
Adaptor primers in general do not bind to mRNA strands at their GC-rich end in the initial
annealing cycle of PCR-RACE, but in subsequent amplification cycles, bind completely to
transcribed cDNA molecules at a defined site. This avoids the production of cDNAs ofvarying
length found in oligo(dT) primer binding to different sites along the poly(A) tail ofmRNAs and
cDNAs (Moqadam and Siebert, 1994). The increased length and binding specificity of these
molecules, as well as their use at a higher annealing temperature as compared to oligo(dT), make
these primers much more useful in the amplification of large amounts of specific 3'end cDNA
sequences.
2.5.5 Determination of optimal PCR-RACE temperatures
PCR-RACE involves incubation of samples. at the three temperatures needed for strand
denaturation, primer annealing and extension to occur. Double-stranded DNA is typically
denatured by briefly heating -,the ~ample to 90-95°C; annealing occurs generally at 40-00 C
according to the Tm of the most AfT rich primer sequence,while extension take place at 72°C
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(Saiki, 1989). The temperatures in the PCR-RACE procedure used were 95°C denaturing
temperature, 44°C annealing temperature, and 72°C extension temperature.
2.5.6 Determination of optimal denaturation, annealing and extension times
The length oftime that the sample is exposed to the specific temperature of each cycle is
determined by several factors. Saiki (1989) states that "extensive denaturation is unnecessary,
and limited exposure to elevated temperatures helps maintain maximum polymerase activity
throughout the reaction". As well, long annealing times are unnecessary as hybridization is almost
instantaneous due to the large molar excess of primer present in the reaction mix. The length of
time for primer extension can vary according to the length of the sequence being amplified. The
average rate ofprimer extension is 1000 bp per minute (Saiki, 1989). Thus, sufficient time must
be given for the complete sequence to be created. Conversely, excessive incubation time will
permit non-specific amplification products to be produced in large numbers (Saiki et 'aI., 1988).
As the length of the mRNA sequence of interest was unknown, but estimated to be
maximally 1.7kb in length, as observed in the FaRP genes of other invertebrates, an extension
time of2 minutes per cycle was chosen. A relatively long annealing time of 1 minute was chosen
as this process may take longer for the pool of oligonucleotides which may be annealing at
temperatures well below their Tm. The length of time of denaturation was also chosen to be 1
minute.
At the commencement of the PCR-RACE procedure, a 5 minute denaturation was
performed in order to ensure that complete denaturation occured and that any possible
contaminating enzyme activity was stopped. A final 10 minute extension was performed so as
to permit full length final products to be produced.
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2.5.7 Determination of optimal number ofPCR-RACE cycles
The number of PCR amplification cycles used is determined by the amount of product
needed, with an increasing number of cycles resulting in increasingly larger amounts of product.
However, Chellyet aI., (1988) found the "the rate of amplification was exponential for 20 to 30
cycles, after which it decreased drastically and reached a plateau", dependant upon the number
of starting molecules. Thus, 30 cycles of 95°C extension for 1 minute, 44 C annealing for 1
minute, and 72°C extension for 2 minutes were performed.
2.5.8 cDNA enrichment
As a mixed oligonucleotide primer was being used to amplify a sequence or sequences
which may be in low abundance, 'a process of "cDNA enrichment" was performed. In this
process, three initial PCR-RACE cycles were performed at lowered annealing and extension
temperatures, permitting sequences with varying degrees of homology to the different
oligonucleotides to be amplified. This results in an "enriched" source of likely sequences for
amplification at higher, more stringent temperatures (Delort et aI., 1989).
2.5.9 Determination of optimal cDNA, enzyme and primer concentrations
Mullis (1989) states that "the success of the PCR reaction depends on the kinetic
advantage that high concentrations ofprimers have over relatively low concentrations of product
strands, which at equilibrium would rehybridize with each other and displace the primers". Thus,
primer concentrations between O.l11M and 111M, and cDNA concentrations of 200ng/mL are
generally used (Saiki, 1989)~ Enzyme concentrations must also be comparatively high, as
sufficient enzyme must be available for primer extension immediately after primer hybridization
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to acheive high-gain amplification. Thus, enzyme concentrations of 5-15 units(U)/I0011L are
commonly used (Mullis, 1989). Consequently, primers used in these reactions were at O.3uM
concentrations, while enzyme was at a 5U/10011L concentration.
2.5.10 Determination of optimal dNTP concentrations
The concentration ofthe four dNTPs used (dATP, dCTP, dGTP and dTTP) was 0.2mM
each. Saiki (1989) states that "of each dNTP, 20011M is sufficient substrate to synthesize over
20 mg ofDNA in a 10011L reaction and generally offers a good compromise between yield and
fidelity. II
2.5.11 Determination of optimal buffer composition
Composition of poly~erasebuffer is an important factor in determining the success of
PCR amplifications. The working concentration of KCI is generally 50mM (Saiki, 1989), a
concentration which facilitates primer annealing without the accompanying inhibition of
polymerase activity that occurs at higher KCI concentrations (Innis, 1990). Tris.CI (between pH
7.3 and 8.8) is generally used at concentrations ofl0 - 50mM (Innis, 1990). Saiki (1989) reports
that "optimal levels (ofNaCI) will vary depending on the sequence being amplified and the nature
ofthe primers. In most cases, best results with genomic targets are obtained in reaction with 0.5 -
1.0 mM free magnesium. (Because deoxynucleotide triphosphates quantitatively bind Mg2+, the
amount of free Mg2+ available for Taq polymerase is the concentration of MgCl2 less the total
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concentration of dNTPs).1I Thus, with each dNTP at a working concentration of 0.2mM, a
working concentration of 1.5mM MgC12 is added, resulting in a free Mg2+ concentration of:
1.5mM MgC12 - 4(0.2mM dNTPs) = 0.6mM free Mg2+.
Gelatin, which acts as an enzyme stabilizer in PCR reactions (Innis et aI., 1988) was
present at a recommended working concentration of 100mg/mL (Innis, 1990).
Addition of 10% glycerol to PCR buffer was reported to maximize efficient specific
amplification (Li and Negre, 1993), and thus the addition of 10% glycerol was assayed to
determine if it increased product yield.
2.5.12 PCR - RACE Procedure Used
The final PCR-RACE procedure determined was the addition ot: in the order given:
31.5 llL sterile H20
5 llL lOx PCR buffer
lllL each dNTP (@ lOmM)
0.5 llL Taq polymerase (@ 2.5U/mL)
3 llL NOT1 primer adaptor (@ 5mM)
2 llL mixed oligonucleotide primer (@ 5mM)
3 llL cDNA (@ 3.3 ng /llL)
Sterile mineral oil was thinly layered over this reaction mixture to prevent evaporation of
the reaction mixture, and the 500 llL PCR tube smeared with Type 25 Silicone Compound (GC
Electronics) so as to maximize heat conductance from the thermal cycler to the tube. A HybaidR
thermal cycler was used for PCR reactions, with an amplification program of:
1 cycle of 95°C (5 min) 27°C (1 min) 45°C (2 min)
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2 cycles of 95°C (1 min) 27°C (1 min) 72°C (2 min)
30 cycles of 95°C (1 min) 44°C (1 min) 72°C (2 min)
1 cycle of 44°C (1 min) 72°C (10 min)
Immediately after completion of the peR-RACE reaction, samples were placed at -20°C.
2.5.13 Second amplication ofPCR-RACE products
In the second amplification or reamplification ofPCR-RACE products (Cooper and Isola,
1993), identical PCR-RACE reaction components and procedures were followed, except that the
3 llL of sample cDNA used in the first PCR-RACE procedure was replaced with 311L of the
initial PCR-RACE product. .
2.6 PCR-RACE Product Recovery
2.6.1 Agarose gel electrophoresis I
An appropriate volume of 6 x sample buffer (20% glycerol, 2% sodium dodecyl sulfate
(SDS), 0.5% Bromophenol blue in sterile H20) was added to 10 llL ofPCR-RACE product
solution. DNA was separated according to size on 1.2% agarose gel made with O.72g agarose
and 1.2 mL 50 x Tris Acetate EDTA (TAB) running buffer (2M Tris Acetate, 0.05M EDTA pH
8.0) in a total volume of 60 mL. DNA was separated alongside molecular weight standards at
60V for 3 hours. The gel was immersed in 0.1 llg/mL ethidium bromide for 20 minutes in order
to stain the DNA, then imm~rsed in distilled water to remove any unincorporated ethidium
bromide. The stained gel was then placed under UV light and photographed. IfDNA bands were
to be recovered from the gel, low-melt agarose was substituted for regular agarose.
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2.6.2 Recovery ofDNA from low-melt agarose gels
DNA bands of interest were cut from low-melt agarose gel with a razor blade, then
isolated from the agarose by either the Glassmax DNA isolation and purification procedure
(Geneclean) or the inexpensive alternative to glassmilk for DNA purification (Boyle and Lew,
1995). The underlying principles in both of these procedures are the binding capacity of silica-
based matrices for DNA from, neutral solutions, washing of the bound DNA to remove soluble
impurities, and elution ofcleaned DNA from its matrix into a solubilizing H20 solution. The small
amounts of DNA recovered were not able to be quantitated spectrophotometrically. DNA
samples instead underwent fluorescence intensity comparison with standards of known DNA
concentration in the ethidium bromide fluorescent quantitation of the amount of double-stranded
DNA method ofManiatis et al. (1989).
2.7 Cloning ofPCR-RACE Products
The study of individual pieces of cellular DNA only became possible with the advent of
recombinant DNA procedures (Watson et aI., 1987). DNA fragments containing sequences of
interest, such as PCR-RACE products, can be replicated in bacteria or mammalian cells in a
procedure termed cloning which allows sequences of interest to be amplified so that they can be
obtained in sufficient quantities for nucleotide sequence analysis and other uses (Miller et aI.,
1983). In the cloning procedure, plasmids, which are small circular DNA molecules that replicate
independently ofhost cell DNA, are cleaved at specific sites by specific restriction endonucleases
and ligated to sequences ofinterest by ligase enzymes, and the recombinant plasmids are inserted
into competent host bacterial cells. (Miller et aI., 1983). The ability of plasmids to confer
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antibiotic resistance to their host is useful for DNA cloning, since this provides a selection
mechanism for obtaining the desired clones.
Selection ofappropriate plasmids and host cells is essential for optimal cloning efficiency
ofthe received products. Bacterial plasmids can range in size from 1kb to more than 200kb, and
may confer phenotypes upon their bacterial hosts such as resistance to antibiotics, production of
antibiotics, degradation ofcomplex organic compounds and production of coli and enterotoxins,
and restriction and modification enzymes (Maniatis, et aI., 1989). The copy numbers of different
plasmids in their hosts vary from 1 to 700 per cells. Different plasmids use different subsets of
enzymes to duplicate the bacterial chromosome for their own replication, and so copy number can
be influenced by the "compatibility" of the enzyme substrates used by the bacterial host and the
chosen plasmid. (Maniatis et aI., 1989). Plasmids vary in size, with smaller plasrnids being
preferred for many reasons. As efficiency of transformation is inversely related to plasmid size,
smaller plasmids are preferred as they can accommodate larger segments of DNA before the
efficiency of transformation begins to deteriorate. Larger plasmids replicate to lower copy
numbers and so yield less inserted DNA. Finally, larger plasmids are more difficult to characterize
by restriction mapping. Thus, the number, placement and identity of restriction endonuclease sites
on the plasmid, as well as plasmid size and copy number within the host are all important
determinants in choosing a particular plasmid. Host cells must also be determined with regards
to growth rate, compatibility with the plasmid vector both in regards to copy number within the
host and ease ofdetection ofrecombinant cells, and the host cell degree of competency (Maniatis,
1987).
It is necessary to ascertain whether the DNA sequences inserted into the plasmid vectors
are those of interest. Hybridization techniques are used to ascertain that the plasmid insert
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sequences are the amplified products themselves, that they recognize crayfish DNA sequences,
and that they recognize sequences in RNA isolated from neuropeptide-transcribing tissues.
2.7.1 Plasmid isolation and purification
The plasmid used in the cloning ofPCR-RACE amplification products was pUC 19
(represented diagramatically in Figure 4), which contains a single Hinc II restriction endonuclease
site within its multiple cloning site, and for which specific forward and backward primers
immediately outside the multiple cloning site are readily available.
Linearization of plasmid DNA at the Hinc II site was performed by means of incubation
with Hinc II enzyme and its appropriate restriction enzyme buffer at 37°C until complete
linearization of the plasmid is achieved; as judged by the size of plasmid bands on agarose gels.
As Maniatis et al. (1987) state "during ligation in vitro, bacteriophage T4 DNA ligase will
catalyze the formation of a phosphodiester bond between adjacent nucleotides only if one
nucleotide contains a 5'-phosphate group and the other contains a 3' hydroxyl group". Thus, in
order to ensure that plasmid contaminants did not ligate to the plasmids, and also to prevent
plasmids from religating themselves, dephosphorylation ofplasmids was performed in some cases.
Thus, DNA sequences of interest with 5' terminal phosphates can efficiently ligate to the
dephosphorylated plasmids. The dephosphorylation procedure used was that ofManiatis et al.
(1987) in which calfintestinal alkaline phosphatase (CIP) is used to remove 5' phosphate groups
from linear DNAs.
RACE products were rendered blunt-ended by the Klenow fragment DNA Polymerase
I reaction (Maniatis, 1989) in some cases in order to optimize blunt-end ligation to Hine II
linearized pUC 19. The Klenow fragment ofE. coli DNA Polymerase I employs its 5' -> 3'
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Figure 4: Figure depicting the plasmid pUC 19 used for ligation to PCR-RACE amplification products (as taken from
Promega technical bulletin). This figure shows the restriction sites of those enzymes which cut the plasmid either once
or twice. Unique restriction sites are depicted in bold type. The positions of the pUC 19lac Z region (lac Z), origin
of replication (ORl), and B-Iactamase gene (Ap) are shown. The polylinker cloning site, in which the plasmid was
cleaved and amplification products were inserted, is shown in detail at the bottom of the page, with both base sequences
and restriction endonuclease sites shown. I
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polymerase activity to fill in recessed 3' ends of double-stranded DNA (Cobianchi and Wilson,
1987).
2.7.2 Ligation
When the Hine II-digested pUC 19 plasmid was used in ligations, 20ng ofPCR-RACE
product was added to 211L 10 x ligase buffer (250mM Tris-HCI at pH 7.5, 50mM MgCI2, 25%
(w/v) polyethylene glycol 8000, 5mM DTT, 4mM ATP), 200ng ofHinc II-digested pUC 19, ll-lL
T4 DNA ligase @ 400,000 U/mL, 'and sterile H20 to bring the total reaction volume to 2011L.
This mixture was incubated overnight at 16°C.
Alternate ligation procedures were also used in order to overcome the problems ofblunt-
end ligation caused by DNA polymerases producing PCR-RACE products with a 3'-dA overhang.
The first method involves the restriction of plasmids with Sac I, generating a 3' overhang with a
terminal dT which can base-pair with the 3'-dA-overhang of the PCR-RACE product. The
second method involves a single-tube ligation in which digestion of plasmid DNA, rendering
PCR-RACE products blunt-,ended, and ligation of plasmid and PCR-RACE products are
accomplished in a single step. In this procedure, Taq DNA polymerase blunt-ends PCR-RACE
products by 3' exonuclease activity in the presence ofdNTPs, and SmaI digests the plasmid DNA
and forces the PCR-RACE product into the plasmid by continuously cutting self-ligated vector
DNA (Chuang et aI., 1995).
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2.7.3 Preparation of competent cells
DHSa cells were grown up overnight from frozen cell stocks (Promega) in LB broth as
described by Maniatis et al. (1982). Cells were rendered competent by the procedure outlined
by Maniatis et al. (1987). In this procedure, bacterial cells are induced into a transient state of
"competence", during which they permit the uptake of foreign DNA. Efficiency ofDNA uptake
is increased with exposure to combinations ofDMSO and reducing agents. The means by which
these agents act to render bacterial cells competent is unknown, as is the mechanism by which
foreign DNA enters these cells (Maniatis et aI., 1987).
2.7.4 Transformation of competent cells
100 llL preparations of competent DHSa cells were transformed with the previously
ligated plasmid-insert as per the procedure ofManiatis et al. (1987), in which DNA is allowed to
enter competent cells until cells are heat-shocked to end their period of "competence" and to
retain the foreign DNA inside the bacterial cells.
2.7.5 Plating of transformed cells
Transformed cells were plated onto LB agar plates (1 ogIL bacto-tryptone, Sg/L bacto-
yeast extract, 1ogIL NaCI, 15g/L bacto-agar, 10mM MgS04 at pH 7.0) with 20mg/L ampicillin
and 20mgIL X-Gal) in 10, 50, and 100 llL aliquots. After the solutions had been absorbed into
the agar, plates were inverted and incubated overnight at 37°C.
White colonies (postulated to be competent cells transformed with plasmid containing the
PCR-RACE product) were picked with a sterile toothpick, and transferred to a gridded LB Amp
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X-Gal plate, and also used to innoculate LB Amp media (1ogIL bactotryptone, 5gIL bacto yeast
extract, 10 gIL NaCI, 20mgIL ampicillin at pH 7.0) which was then incubated overnight at 37°C
for maximal colony growth.
2.7.6 Colony lifts
Selected colonies transferred to gridded agar plates were inverted and incubated overnight
at 37°C to allow colony growth. Colonies were then transferred onto nitrocellulose membranes
for use in colony hybridization.,as per the protocol ofWaW et al. (1981). This protocol transfers
colonies to nitrocellulose membranes, isolates and immobilizes DNA from these colonies and
allows the membranes to be stored until they can be used in hybridization experiments. In this
standard protocol, a suggested modification was used that after colonies had been transferred to
the nitrocellulose membrane from the agar plate, the membrane was placed onto filter paper
saturated with 10% SDS for 3 minutes prior to being placed on filter paper saturated with O.5N
NaOH for 5 min. This modification aids in the isolation of plasmid DNA and SDS, a detergent,
causes aggregation and binding of host cell wall proteins.
2.7.7 Isolation of plasmid DNA from colonies
The selected colonies used to innoculate 2mL ofLB amp medium were grown overnight
with shaking at 37°C. Recombinant plasmid DNA was then isolated from the resultant bacterial
broth by the "Harvesting and lysis ofbacteria -lysis by alkali" procedure ofManiatis et al. (1987).
The principles underlying this procedure are that exposure ofbacterial cells to EDTA, detergents,
and alkali disrupts base pairing, causing the linear chromosomal DNA of the host to denature.
Due to their being topologically interwined, strands of closed circular plasmid DNA are unable
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to separate from one another. When conditions return to normal, plasmid DNA strands recognize
their complimentary sequence, and native superhelical molecules are reformed (Maniatis et aI.,
1989).
2.7.8 Determination of insert presence and size
Insert presence and size were determined by restriction enzyme analysis of isolated
plasmid DNA of interest. DNA from both intact and recombinant plasmids was digested to
completion with a single restriction endonuclease which cuts once within the plasmid, to
determine insert presence and to provide an indication of its size. The length of the linearized
DNA fragments was then compared. Plasmids were also cut with a restriction enzyme that.cut
the plasmid once at each side of the ligation site, or with two restriction enzymes, each of which
cut the plasmid once on opposite sides of the ligation site. When run on an agarose gel, band
sizes were again compared to determine insert size and presence.
2.8 Selected cDNA Library Creation
2.8.1 cDNA library creation
The selected cDNA library was formed using the selected EcoR! linker-dscDNA
fragments which had been purified on an A5M-column. These fragments were ligated to EcoR!
digested Agt11 (Promega) (see Figure 5) as per manufacturer's direction, and the ligated DNA
was used in the transformation of YI088 bacteriophage cells using the Packagene in vitro
packaging system (Promega).
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Figw-e 5: Figure depicting the vector Agtll used for ligation to selected dscDNA fragments (as taken from Promega
technical bulletin), and subsequently cloned in YI090 cells in the creation of a selective cDNA library. This figure
shows the EcoR! site into which the dscDNA fragments were inserted in bold type. Other restriction endonuclease sites
are also shown, as is the position of the lac z region.
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2.8.2 Titre increase
Phage titre, that number of plaque forming units per mL of phage solution, is increased
by adding 20011L of~ackagene mixture, 20011L YI088 cells, and ImL ofLB broth with 0.2%
maltose. This mixture is incubated overnight at 37°C. 5011L of chloroform is then added, the
mixture is incubated for 15 minutes to break open bacterial cells, and then centrifuged briefly to
precipitate cell debris.
2.8.3 Isolation of plasmid DNA from plaques
Recombinant plasmid DNA was recovered from plaques according to the method outlined
by Paula Argenta (1993).
2.8.4 Determination of insert presence and size
Detennination ofthe presence ofselected dscDNA sequences within the Agtll vector was
petfonned by means ofPCR amplification of the lac z region into which these sequences would
be inserted. The primers used were ALC-2 (5' CAGGAAACAGCTATGAC 3'), a reverse primer,
and ALC-4 (5' GTAAAACGACGGCCAGT 3'), a forward primer. These primers are 70bp apart
from each .other and are located on either side of the EcoR! insertion site. As the melting
temperatures of ALC-2 and ALC~4 are 50°C and 52°C respectively, the annealing temperatrue
was selected to be 48°C. An initial PCR cycle of 95°C(5 min), 48°C(1 min), 7Z'C(1 min) was
performed, followed by 40 cycles of95°C(1 min), 48°C(1 min), 72°C(1 min) , and a final cycle
of48°C(1 min), 72°C(lO min). Insert size and presence was calculated by determination of the
received amplification product band. In order for an insert to be present, the obtained product
must be greater than 102bp (the 70bp distance between the ALC-2 and ALC-4 primers + the
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32bp size of the two primers themselves). The additional size of the received product band
reflects the vector insert size.
2.9 Hybridization procedures
Hybridization was performed on colony lifts and DNA dot blots.
2.9.1 Preparation OfLabelled Probe
The PCR-RACE amplification products used in cloning were also used as probes to
ascertain both that these sequences were successfully cloned into the selected recombinant clones,
and also to determine if the amplified sequences were present in the RNA of different tissue~ of
the crayfish Procambarus clarkii. Amplification products were 32p labelled by Nick Translation
(Promega Technical Bulletin). In this procedure E. coli DNA polymerase I combines the
sequential addition of radioactive nucleotide residues to the 3' - hydroxyl terminus of a nick,
generated by DNAse I, with the elimination of nucleotides from the adjacent 5' phosphoryl
terminus (Meinkoth and Wahl, 1987).
2.9.2 Measurement ofRadiolabel Incorporation
The percentage of radiolabel incorporation into the hybridization probe was determined
to evaluate probe viability and to assess the amount of probe required to emit a readily detectable
signal.
In this procedure, 1pL ofr~diolabelled probe was added to 9911L ofO.2M EDTA. In
order to measure total probe radioactivity, 10pL of the diluted probe was spotted onto a
glassfibre filter which was then placed in a scintillation vial. In order to measure incorporated
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radioactivity, another 1011L of diluted probe was added to 10011L of 10mg/mL salmon sperm
carrier DNA in a test tube on ice. 3mL of ice cold 10% trichloroacetic acid (TeA) was added
to the test tube, which was left on ice for 10 minutes. The solution was filtered onto a glassfibre
filter. The test tube was washed 5 x with 3mL of 10% TCA, which was subsequently added to
the glassfibre filter. The filter was then washed with cold 95% ethanol, and placed into a
scintillation vial. Scintillation fluid'was added to both vials, and their respective radioactivities
in cpm units were determined using a Beckman LS 1800 scintillation counter. Percentage
radiolabel incorporation was determined by the equation:
# of cpm incorporated radioactivity x 100%
# of cpm total radioactivity
There must be at least 20% radiolabel incorporation for the probe to be used so as to
minimize non-specific radiolabel binding and background radioactivity levels.
The amount of incorporated radiolabel per llL of probe is equal to lOx the # of cpm
incorporated radioactivity.
To obtain a signal intensity that is readily detectable, the probe must contain at least
1,000,000 cpm of incorporated radiolabel. Thus, in determining the amount of incorporated
radiolabel per llL of probe, the amount of probe needed can be determined.
2.9.3 Hybridization
The hybridization procedure used was adapted from the procedure of Hybaid™.
Membranes were prehybridized for 1 hr with agitation at 65°C in sealed pastic bags with 10 mL
ofprehybridization solution (6 x sse [20 x sse stock:3M NaCI, O.3M Sodium citrate]), 0.5%
sodium dodecyl sulfate (SDS), 5 x Denhardt's Solution [1% Ficoll, 1% polyvinyl prolidine, 1%
bovine serum albumin] and 5011g/mL salmon sperm DNA boiled for 5 minutes, then chilled on
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ice). Prehybridization procedures are used so as to preempt nonspecific nucleic acid binding on
the solid supports, and so reduce background hybridization. For hybridization, probe (containing
at least 1,000,000 cpm of incorporated radiolabel) was denatured by boiling for 5 minutes, then
chilled on ice prior to addition to prehybridization solution. Hybridization was allowed to occur
overnight with agitation at 65°C. Stringency washes were performed as per Hybaid technical
bulletin, with SSC used instead of SSPE.
Once washed, membranes were placed on a solid support, covered with plastic wrap, and
exposed to Kodak X-OMAT film with a Cronex intensifying screen overnight at -70°C. X-ray
films were developed by an imtial 5 minute submersion in Kodak GBX developer, 1 minute in
distilled water, and 5 minutes in Kodak GBX fixer. The film then underwent a final 1 minute
wash in distilled water.
2.10 Sequencing
Sequence determination ofPCR-RACE amplification products is performed in order to
determine if amplification products are FaRP-encoding sequences, to determine base pair
homology with known seque!1ces, and to assess stringency of mixed oligonucleotide primer
binding. DNA sequence analysis is a molecular cloning technique which determines the
nucleotide sequence of DNA. Sequencing is commonly used either to determine the site of
mutation ofa known gene, or to determine the entire nucleotide sequence of an unstudied DNA
segment (Promega technical bulletin). The two sequencing techniques currently in use are the
chemical degradation method ofMaxam and Gilbert (1977) and the dideoxy method of Sanger
et al. (1977).
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2.10.1 The Sanger method
The Sanger method, developed in 1977, generally involves the sequencing ofDNA by a
procedure that involves second-strand DNA synthesis until there is incorporation of a specific
radioactively labelled dideoxy nucleotide base, which prevents further chain extension. DNA
sequence is found by determining the type of dideoxy base terminally incorporated in sequences
of increasing length.
In this method, a template DNA molecule is initially prepared. This single-stranded DNA
fragment is then annealed to homologous single-stranded primer. Primer homology is assured
as both the template and the primer come from the same original double-stranded DNA fragment.
The double-stranded DNA fragment is produced by site-specific cleavage of a DNA polymer.
One portion of the resultant fragment sample is treated with another restriction enzyme, which
produces a smaller double stranded fragment, which is dissociated to produce two small single
stranded fragments, one ofwhich is used as the primer. A second portion of the original fragment
sample is used to make a template DNA strand. An exonuclease is used which cleaves single
nucleotides from the 3' ends of the double stranded DNA fragment. The exonuclease is then
removed, and DNA polymerase is added. With the addition of deoxynucleotides (e.g. dATP,
dGTP and CTP) and a dideoxynucleotide (e.g. ddTTP), the DNA strand is re-elongated at the
3' end until the dideoxynucleotide is incorporated (in this case when a T is required to base pair
with the A present on the opposite strand). With this dideoxynucleotide incorporation, the 3' end
ofthe template DNA strand is blocked from further elongation as the lack of a 3' hydroxyl residue
in dideoxy nucleotides prevents formation of a phosphodiester bond with the succeeding
deoxynucleotide (Maniatis et aI., 1989). This blocked template solution is heated to denature the
template strands, and the solution is combined with the primer solution. At this point, the
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template DNA reanneals with the homologous primer DNA, resulting in double-stranded DNA
in which the shorter primer can undergo 3' end extension according to the base sequences
provided by the template, but the template cannot be extended at its 3' end due to its prior
incorporation of a dideoxynucleotide.
A control solution containing the entire range of extended primer lengths is subsequently
prepared. In this procedure, the template-primer DNA fragment is combined with DNA
polymerase and the four dNTPs, one of which is 32P-Iabelled to generally identify newly
synthesized primer extensions." As the polymerase extends the 3' end of the primer, aliquots are
removed at given timed intervals and frozen to stop the elongation reaction. Recombination of
these aliquots provides a control solution comprising the entire range of extended primer len~hs.
Finally, four separate reactions containing the template-primer solution, three dNTPs (one
ofwhich is 32p-Iabelled), and a given concentration ofone ddNTP along with its equivalent dNTP,
are run. In each of the four reactions, a different ddNTP is included. As previously, extension
ofthe primer occurs only ifthe appropriate dNTP, and not its equivalent ddNTP, is incorporated
at a specific base pair position. Due to the presence ofboth the dNTP and ddNTP equivalents,
primer extension lengths vary depending on which is incorporated at each specific base pair
position. The resultant extended DNA fragments ofvarying lengths are then hydrolyzed from the
primer by treatment with a specific restriction endonuclease. Polyacrylamide gel electrophoresis
of the four test solutions and the control separates the fragments according to length, and
visualization ofthese 32p labelled fragments is done using autoradiography. Fragment lengths are I
I
compared to the control autoradiograph, and the DNA sequence is determined by reading the
base type of the incorporated ddNTPs in fragments of increasing length (Wood, 1984).
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Recent modifications and improvements have been made to the Sanger method of
sequencing. Several enzymes other than the Klenow fragment ofE. coli DNA polymerase I can
be used for primer extension in ways which can significantly affect the quantity and quality of the
DNA sequence of interest (Maniatis et aI., 1989). The Klenow fragment has a low processing
rate, and so there is often a high background of fragments that terminate due to random
disassociation of the polymerase from the template, and not by ddNTP incorporation. As well,
this enzyme is not able to travel long distances along the template, thus limiting the lengths of
obtained sequences to 250 - 350 nucleotides. Finally, this Klenow fragment cannot efficiently
copy regions of high secondary structure in the template. As a result of these problems, other
enzymes are now also used in dideoxy nucleotide sequencing. Reverse transcriptase, altho~gh
not routinely used in sequencing, can be used to resolve problems caused by homopolymeric
regions of AfT or G/C in the template DNA. Taq DNA polymerase is also used to determine
DNA sequences that normally form extensive secondary structures, as it can work efficiently at
high temperatures which preclude secondary structure formation. Finally, both Sequenase TM
and Sequenase version 2.0 (which has no 3' -> 5' exonuclease activity and has a higher
processivity than Sequenase TM) are used for determining long DNA sequences. Both of these
have extremely high processivity, high rates of polymerization, and a wide tolerance for
nucleotide used to resolve compression regions in sequencing gels (Maniatis et al. 1989).
Sanger DNA sequencing was originally carried out with [cx- 32p] dNTPs. However, ~­
particle emissions by 32p caused scattering, resulting in large diffuse autoradiograph bands that
were difficult to read. As well, 32p decay caused radiolysis of sample DNA, limiting the storage
life of the sequencing reactions to 1 or 2 days. The use of [35S] dATP greatly reduced these
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problems, as it has reduced scattering due to the presence of weaker ~ particles, and has less
radiolysis. This allows sequencing reactions to be stored up to 1 week (Maniatis et aI., 1989).
Both the Maxam-Gilbert and the Sanger methods ofDNA sequencing are theoretically
sound and functionally useful. The Maxam-Gilbert method is advantageous in that there is a
redundant display of the nucleotide sequence. For example, the use of strong guanine/weak
adenine display, in which there is generally enough information to distinguish both the Gz and the
A2, is more useful than just a pure G pattern alone, as the redundant information serves as a
check on the identification. (Maxam & Gilbert, 1977). However, this same redundancy makes
Maxam-Gilbert's audioradiograms more difficult to read, as it is necessary to deduce the position
ofT residues by subtracting bands. Measuring in the C track from those in the C + T track.. As
well, because Maxam-Gilbert sequencing always employs 32P-Iabelled DNA, the resultant
sequencing bands are fuzzier and broader than those obtained using [35S]dNTPs in the Sanger
method. This lack of resolution of Maxam-Gilbert sequences limits the amount of reliable
sequence in a gel to 200-250 nucleotides. (Maniatis et aI., 1989). The Sanger method of
sequencing is generally favoured over the Maxam-Gilbert method, as alterations and
modifications to this method have been developed allowing for faster, more accurate
determination of longer sequences.
2.10.2 Purification of plasmid DNA for sequencing
Prior to use in sequencing, plasmid DNA of interest was purified by one of two different
procedures. DNA was isolated by either the "Purification of closed circular DNA by equilibrium
centrifugation in CsCI-Ethidium Bromide gradients" procedure ofManiatis et al.(1989) followed
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by the removal ofethidium bromide by I-butanol (Maniatis et al., 1989), or by polyethylene glycol
(PEG) purification.
The former procedure involves separation of plasmid and chromosomal DNA due to
differences in the amount ofethidium bromide which can bind to linear and closed circular DNA
molecules. Ethidium bromide intercolates between bases ofDNA and binds, causing DNA helices
to unwind. As a result of this unwinding compensatory superhelical turns are formed in closed
circular plasmid DNA, which increases density and eventually prevents further intercalation of
ethidium bromide. In contrast, linear molecules continue to bind ethidium bromide until
saturation is reached, and so forms a separate upper band from the denser closed circular plasmid
DNA during density-gradient centrifugation.
In the latter procedure, isolated DNA was washed with 95% ethanol, centrifuged for 10
minutes at 10,000 x g, rewashed in 80% ethanol, and the isolated DNA pellet was allowed to air
dry for 10 minutes. This pellet was then resuspended in 0.5mL TE buffer containing 5011g/mL
RNAse A, and incubated for Ihr at 37°C. 0.5mL of25:24: 1 phenol:chloroform:isoamyl alcohol
was then added to the DNA solution, and this mixture was centrifuged for 2 minutes at 10,000
x g to separate DNA in the aqueous phase from protein and digested RNA contaminants in the
phenol phase. The upper aqueous layer was extracted, with 1mL of95% ethanol and 10011L of
7.5M NH4Ac added. This mixture was incubated 30 minutes at -20°C, then centrifuged 10
minutes at 10,000 x g at 4°C, and allowed to dry. The pellet was resuspended in 5011L of IE
buffer, 3011L of 20% PEG in in 2.5M NaCI added, and the mixture was incubated on ice for 1-
2hrs. The mixture was then centrifuged for 10 minutes at 10,000 x g at 4°C. The PEG
supernatant was drawn off carefully, the pellet was washed in 80% ethanol, centrifuged 10
minutes at 10,000 x g, allowed to dry, and finally resuspended in 35pL of sterile water.
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2.10.3 Denaturation of double-stranded plasmids
3-511g ofdouble-stranded plasmid were denatured using the alkaline denaturation method
ofHaltiner et al. (1985) which uses strong base in order to hydrolyze the H-bands between the
two DNA strands.
2.10.4 Sequencing gel preparation.
Sequencing gel plates and dividers were thoroughly washed with soap and water and were
rinsed with 70% ethanol prior to sequencing apparatus assembly. Plates were washed with 0.1%
sodium dodecyl sulfate (SDS), and the "upper" plate (to be removed from the gel after
electrophoresis) was treated with Repel-Silane (phannacia Biotech) so as to prevent gel adhesion
to that plate. The sequencing apparatus was assembled according to directions in the Bio-Rad
Sequi Gen(R)Nucleic Acid Sequencing Cell Instruction Manual.
Sequencing gels were composed of 100mL of sequencing gel solution (420gIL urea,
220mLIL of5 x TBE [54gIL Tris base, 27.5gIL boric acid, O.OIM EDTA, pH 8.0], 100mLfL
30% Bis-acrylamide, 110mLIL 2% sequencing acrylamide). This solution was degassed for 15
minutes, then a gel "plug" was poured by combining 10 mL of sequencing solution with I011L of
N,N,N',N'-tetramethylethylenediarnine (TE:MED), a polymerization initiator, and 1011L offreshly
prepared 25% ammonium persulfate (APS), a polymerization catalyst (Ogden and Adams, 1987).
Once this plug was polymerized, the remaining gel solution, combined with 9011L of25% APS
and 90pL TE:MED, was poured into the apparatus, a plastic strip was inserted horizontally at the
top of the gel to limit gel height, and the gel was allowed to polymerize.
Once polymerized, the gel apparatus was assembled into the complete sequencing
apparatus with 350-500mL of 1 x TBE buffer in the lower chamber, and 1.5L of 1 x TBE buffer
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in the upper chamber. The upper plastic strip was replaced with a tooth comb which created
"wells" for sample insertion into the gel. The gel was run for 30-60 minutes at 1800V prior to
sample application in order to acheive optimal gel temperature of 45-55°C.
2.10.5 Sequencing reactions
In the sequencing reactions, specific primers were used to sequence the Hinc II inserts of
the pUC 19 plasmids and the EcoRI insert ofi\gt11. ALC-2 (5' CAGGAAACAGCTATGAC 3'),
a reverse primer which binds from position 481 to position 465 of pUC 19, or ALC-4(5'
GTAAAACGACGGCCAGT 3'), a forward primer which binds from position 379 to position 395
ofpUC 19, were annealed to the denatured double-stranded templates. Second strand synthesis
with radiolabel incorporation was allowed to occur, and strand termination with incorporation
ofspecific ddNTPs was performed according to the procedures ofUSB technical bulletins. Either
[a_32p] dATP or [a_35S] dATP were used in reactions.
2. 10.6 Running sequencing gels
Samples were heated to 72°C 2 minutes immediately prior to loading onto the sequencing
gel. 2-3pL ofeach sample was loaded onto the pre-warmed gel, which was then run for 2-4hrs
at 1800V. When electrophoresis was completed, buffer was removed from the gel apparatus, the
clamps were removed from the gel plates, and the upper gel plate was removed, exposing the
sequencing gel. Whatman 3M filter paper cut to the size of the gel was placed upon the
sequencing gel. The sequencing gel adherred to the filter paper and could then be removed from
the "lower" sequencing plate. The gel side of the filter paper was covered with plastic wrap, and
was dried in the Bio-Rad Model 58.3 gel drier for 45 minutes at a steady temperature of 80°C.
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Once dried, the plastic wrap was removed from the gel, and the gel was exposed to a Kodak
OMAT-AR x-ray film overnight at -70°C. X-ray films were developed as previously mentioned.
Determined sequences were sent to the El\1BL FASTA server in Heidelberg, Germany DE data
base (E-mail: FASTA@EBI.AC.UK) for sequence comparison.
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RESULTS
Procambarus clarkii total RNA was isolated from the suboesophageal and thoracic
ganglia: known FaRP-transcribing tissues. RNA quality was assessed both
spectrophotometrically and by gel electrophoresis. mRNA was then isolated from total RNA
either by oligo-dT cellulose column purification or by use of the Poly Attract mRNA Isolation
System (Promega). First strand cDNA was then synthesized for use in PCR-RACE reactions.
Prior to the use of sa~ple cDNA in PCR-RACE reactions, optimization of PCR and
PCR-RACE reactions was performed using control cDNA of known size and sequence. While
no observeable products resulted from PCR reactions in which a buffer composed of 500mM
KCI, 100mM Tris.CI and 15mMMgC12 was used, PCR reactions produced observeable products
ofcorrect size when a 10 x buffer composition of 500mM KCI, 100mM Tris.CI (pH 8.3 at room
temperature), 15mM MgCl2 buffer and 0.1% gelatin was used (Figure 6). Correspondingly, it
has been reported that the use ofgelatin improves enzyme binding (Innis et al., 1988).
Although Li and Negre (1993) report that the use of 10% glycerol maximizes efficient
specific amplification, PCR-RACE amplifications of control cDNA of known amplification
product band size in the presence of 10% glycerol were observed to have little positive effect or
a largely negative effect upon the quantity ofPCR-RACE product received (Figure 7). In the
amplification of Ustilago violacea cDNA between the oligo (dT) type NOT1 primer and the AC2
primer (a control reaction in which products of a known size are obtained), the presence of 10%
glycerol in amplification reactions resulted in a much lower yield of product than in those
reactions perfonned without glycerol present. However, in the amplification of Ustilago cDNA
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Figure 6: This figure shows the optimization ofthe polymerase chain reaction (PCR) procedure with regards toreaction
buffer composition. Lane C depicts the amplification product of the recombinant plasmid 9-1, using the primers ALC I
andALC2 and a 10 x buffer composition of500mM KCI, IOOmM Tris.CI (pH 8.3 at room temperature), and 15mM
MgCI2• Lane A depicts the amplification products of 9-1 using the primers ALC I and ALC2 under identical reaction
conditions, with the addition of 0.01% gelatin. Lanes B and D represent negative controls which lack 9-1 DNA. D
was amplified in gelatin-free conditions, while B was amplified in the presence of 0.01 % gelatin.
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Figw-e 7: Figw-e depicting the effect of glycerol upon the yield and size ofPCR-RACE amplification products. Lanes
A and B both contain the amplification products of control reactions usingUstilago cDNA between the oligo (dT) type
NOTI primer and the AC2 primer, vvith amplification occuring in the presence of 10% glycerol in the lane B reaction
mixture. Lane C represents a negative control which lacks cDNA, but contains both AC2 and NOn primers, while
lane D is also a negative control; containing AC2, NOTI and 10% glycerol. Lanes E andH both contain the
amplification products ofcontrol reactions using Usti/ago cDNA between the oligo(dT) type NOTl Primer and the AC 1
primer, with amplification occuring in the presence of 10% glycerol in the lane H reaction mixture. Lane F is a negative
control which lacks eDNA, but contains both AC I and NOTI primers, while lane G contains ACI , NOTI and 10%
glycerol. Lane I is a positive control ofkno\vn amplification product size, used to ensure that the PCR reactions are
working properly.
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between the NOTI primer and the ACI primer, little difference was observed between products
amplified in the presence of 10% glycerol. The use of "eDNA enrichment" procedures, in which
three cycles of low stringency amplification precede high stringency cycles, was tested using
control cDNA in PCR-RACE procedures. No observeable products were formed in the absence
ofeDNA enrichment, while observeable products were formed with the use of cDNA enrichment
procedures (Figure 8).
With optimization of 'general PCR-RACE conditions using control cDNA, the PCR-
RACE procedure was then optimized for the specific mixed oligonucleotide primer and
generalized NOT1 adaptor-primer (promega) ofProcanlbarus FaRP sequence amplification. As
optimal peR-RACE annealing temperatures are reccommended to be 2-4°C below the lowest Tm
ofthe primers, reactions were performed at annealing temperatures of 42°C and 44°C. At 42°C,
no obseIVeable product was fonned, while at 44°C, a product band approximately lOObp in length
was observed (Figure 9).
FaRP mRNA sequences ofProcanlbarzis clarkii are assumed to possess multiple copies
of FaRPs; as deduced from known invertebrate FaRP mRNA sequences. The frequency of
occurance of FaRP mRNA transcripts within Procambarus tissues is unknown. peR procedures
are known to preferentially amplify shorter sequences when more than one possible amplification
sequence exists, and primers may have difficulty locating and binding to rarely occurring mRNAs.
In order to avoid these problems, second strand eDNA synthesis of sequences recognized by the
mixed oligonucleotide primer was performed. These selected sequences were ligated to EcoRI
linkers and purified by passage through A5M-columns.
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Figure 8: Effects ofPCR-RACE cDNA errrichment upon product yield are shown in this figure. Lanes A and B show
PCR-RACE products using three preliminary cycles of cDNA errrichment in which lowered annealing temperatures
are used. In these lanes, products approximately 100bp in size are visible, in contrast to lanes C and D, in which no
product is visible. Lanes C and D contain the products of identical PCR-RACE procedures, lacking the tlrree initial
cDNA enrichment cycles.
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Figure 9: Figure depicting the optimization of PCR-RACE annealing temperatures. Lane D represents the
approximately lOObp amplification product of Procambarus suboesophagel and thoracic ganglia cDNA using the
mixed oligonucleotide NFLRF(Gly) primer and the NOTI primer at a 44°C annealing temperature. The lack of
observeable product in lane F is a result of identical reaction mixture being esposed to a 42°C annealing temperature.
Lanes A, B, and C were negative controls perfonned at 44°C, while lanes G, H, and I were negative controls perfonned
at 42°C. Lane E was a positive control penonned at 44°C.
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Packagene eDNA library fOImation was attempted using ligation ofEcoR! digested J\gtll arms
to 10 llL of synthesized 2U, 1U, and 0.5U Mung Bean Nuclease digested dscDNA. of plaque
formation was performed. This suggests the presence of low concentrations of dscDNA. Blue-
white selection was performed upon plaques grown on LB Amp X-Gal plates, and white plaques
were selected for DNA isolation and investigation of insert presence and size. These white
plaques were replated to ensure the consistency offormation ofwhite plaques. The eight isolated
white plaques were unable to undergo plaque hybridization procedures as the degenerate
oligonucleotide primer used for synthesis of these sequences was observed to hybridize to false
positives in the prior screening oftheProcambarus genomic library (Peaire, 1993). Similarily,
attempts to determine insert size by restriction endonuclease digestion and subsequent agarose
gel electrophoresis failed to yield obselVeable amounts of insert bands due to the small expected
insert size as compared to the large size ofthe :\gtll vector. Thus, presumed inserted sequences
within the Agtll vectors were preferentially amplified using peR procedures (with 40 cycles at
a 48°C annealing temperature). The specific primers ALC2 and ALC4 were used for this
amplification reaction.
These specific primers recognize sequences within the lac z region of Agt11 surrounding
the EcoR! ligation site, thus amplifying that sequence presumably containing the FaRP dscDNA
ofinterest. As the two primers bind to positions on the lac z region that are 70bp apart, the size
ofthe amplification product should be 102bp (70bp + the size of both primers) plus that size of
the ligated sequence. As the observed amplification production sizes of the Agt 11 recombinants
was approximately 100bp in length (Figure 10), the presence of a FaRP sequence insert seems
doubtful.
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Figure 10: This figure shows the results of PCR amplification of Agtll vectors postulated to contain inserted
sequences. Amplification of the lacz region of Agt11 vectores without inserted sequences using the vectors ALC-2
and ALC-4 (as shown in lane A) produces an approximately 100bp amplification product band. Identical amplification
reactions of vectors postulated to contain inserted sequences (as shown in lanes B-H) also produces bands
approximately 100bp in length, indicating an absence of insertion sequences.
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Purified mixed oligonucleotide primed dscDNA was also used as the substrate for PCR-RACE
amplification, avoiding the difficulties ofprimer location of specific sequences encountered when
using total eDNA. Upon amplification, although positive controls produced ample amounts
of full-sized product, only small amounts of approximately 100bp product were observed in
dscDNA samples (Figure 11). Re-amplification of a 311L aliquot of the PCR-RACE reaction
mixture or of isolated reaction product bands performed using the same procedure as for initial
amplification. A sample of O.5U 'Mung Bean Nuclease digested dscDNA was observed to
produce distinct bands approximately 900bp, 750bp, and 450bp in length (Figure 12). These
products were shown to be reproducible; 311L aliquots of the reaction mixtures could be re-
amplified to produce amplified bands of the same length, while 311L aliquots of the reaction
mixtures diluted as for PCR-RACE reactions did not produce observeable bands when run on the
same gel (Figure 13). DNA isolated from the 750bp band, when used as the substrate in PCR-
RACE procedures, produced an amplification product band approximately 750bp in length.
Amplification bands from O.5U, 1U, and 2U Mung Bean Nuclease digested dscDNA were
isolated from low-melt agarose gels, and ligated to pUC 19 plasmids for use in subsequent
transformation of competent cells. Conditions were varied to maximize ligation of plasmid and
insert.
The use ofpUC 19 pla'smid,: although purified by CsCI-banding procedures (Maniatis et
aI., 1989), was marred by the presence ofcontaminating host E. coli DNA sequences. To prevent
ligation of contaminating fragments with plasmids, pUC 19 plamid samples underwent
dephosphorylation (Maniatis et aI., 1987) prior to ligation.
peR-RACE re-amplification products approximately I500bp, 750bp, 500bp, 450bp, and
200bp in size were successfully cloned into the Hinc II site of the pUC 19 plasmid. Initial specific
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Figure 11: This figure shows the amplification products of Mung Bean Nuclease double stranded cDNAs. The
degenerate NFLRF(Gly) oligonucleotide was used to prime second strand synthesis of these selected double stranded
cDNAs (dscDNAs). Lane A is a positive control which produced the expected product band size of approximately
900bp, while lanes B and D are negative controls in which sample reactions lack one of the two primers used (either
the degenerate NFLRF(Gly) oligonucleotide or the NOTI primer). Lane C represents au Mung Bean Nuclease
digested (MEN) dscDNA, while lane E is O.5U MEN dscDNA, and lane Gis 2U MEN dscDNA. All four of these
lanes appear to contain varying amounts of an approximately 100bp product.
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Figure 12: Figure depicting re-amplification products ofO.5U Mung Bean Nuclease digested double stranded FaRP
cDNA in lanes A, B, and C. Specific bands approximately 900bp and 750bp in length are observeable.
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Figure 13: This figure sho\:vs reproducibility of re-amplification products. Lane A shows the PCR-RACE re-
amplification product of O.5U Mung Bean Nuclease (MEN) digested dscDNA, with distinct bands approximately
900bp, 750bp, and 200bp in length. Lane B is that amount ofO.SU MEN dscDNA first amplification product diluted
as for re-amplification procedures. The lack ofvisible product in this lane demonstrate3 that the observed bands in lane
A are not merely the original substrate. Identical dilutions have been performed in lanes D and F corresponding to the
amplification substrates used in lanes C and E respectively. Lane C represents the PCR-RACE re-amplification product
of 1U MEN dscDNA with distinct bands 600bp, 500bp, and 450bp in length. Lane E represents the PCR-RACE
amplification product ofan isolated band of7SObp DNA from the O.5U MEN dscDNA. The observation of the 7S0bp
band being fonned demonstrates the reproducibility of the PCR-RACE products.
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Figure 14: Figure showing insert size in recombinant pUC 19 plasmid. Recombinant plasmids were generated as a
result of the ligation ofHinc II digested pUC 19 with the isolated 750bp and 200bp re-amplification product bands of
O.5U Moog Bean Nuclease digested dscDNA. The t\VO isolated 750bp recombinant plasmids are represented by the
letters A and B, while the two isolated 200bp recombinant plasmids are reresented by the letters C and D. Pvu II
digestion is indicated by the number 1, while the number 2 represents EcoRI digestion. Incomplete digestion by both
enzymes resulted in observeable bands being fOImed due to the presence of both supercoiled and linearized [OIlIlS of
the plasmid. Supercoiled plasmid bands are observeable at approximately 2000bp for samples A and B, and at
approximately 1500bp for samples C and D. Circular plasmid bands are observeable at approximately 4900bp for
samples A and B, and at approximately 4300bp for samples C and D. EcoRI digestion results in linearization of the
recombinant plasmids. In lanes A2 and B2, EcoRI plasmid linearization results in an approximately 3400bp band,
indicating an insert size ofapproximately 700bp (similar to the expected 750bp insert size). In lanes C2 and D2, EcoRI
digestion results in an approximately 2900bp band being produced, indicating an insert size of approximately 200bp
(corresponding to the expected 200bp insert size). Pvu II digestion, vvhich cuts the plasmid on either side of its
multiple cloning site 322bp apart, results in the formation of an approximately 2400bp sequence (pUC 19 (2686bp) -
322bp), in lanes AI, B1, C1, and D 1. Incomplete Pvu II digestion, vvhich results in the linearization of the pUC 19
plasmid, produces bands identical in size to those produced by EcoRI digestion.
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endonuclease digestions ofplasmid DNA isolated from colonies lacking r3-galactosidase activity
(and thus indicating recombination of the pUC 19 plasmid) were performed to determine insert
presence and size, as shown in Figure 14. Figure 14 demonstrates the presence of an insert of
approximately 700bp and 200bp in the transfonnation products of 750bp and 200bp PCR-RACE
products respectively. In order to ensure that actual PCR-RACE products were inserted into the
pUC 19 plasmid, hybridization to colony lifts were performed. Radioactively-labelled PCR-
RACE product probes hybridized to recombinant colonies, indicating successful PCR-RACE
product plasmid incorporation (see Figure 15 for colony hybridizations with labeled 1500bp
product, Figure 16 for colony hybridizations with labeled 750bp product, Figure 17 for 500bp
hybridizations, Figure 18 for'; 450bp hybridizations, and Figure 19 for 200bp hybridizations).
Positive controls, in which radioactively - labeled PCR-RACE products of a given size were
hybridized to the same unlabeled PCR-RACE product, were performed to ensure that
hybridization reactions were being performed under favourable conditions.
Sequence determination of the approximately 1500bp, 450bp, and 200bp products
indicated that these products possessed identical sequences at their 3' and 5' ends. The sequence
amplified by the NFLRF(G)-encoding degenerate oligonucleotide prImer was
AGCTTATAGATACCAGq, with 10 of the 17 bases matching those found in the primer
sequences (bases identical to those found in the degenerate oligonucleotide sequence are printed
in bold type). This amplified sequence does not encode FaRP sequence.
The NOTI adaptor-primer was observed to be similarily non-specific in its binding, with
12 of the 28 bases binding to those found in the primer sequence. The amplified sequence
recognized by NOTI was AGAATCGCAACGTCATGTCATGTTAAGA.
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Figure 15: Figure shovving hybridization Of 32p -labeled 1500bp PCR-RACE product to colony lifts oftransfolmed
DH5a: cells containing recombinant pUC 19 plasmid. The dark spots indicated by arrows are areas of probe
hybridization to DH5a: colonies containing the PCR-RACE 1500bp sequences. Spots not indicated by arrows are
points of false hybridization which do not cOlTespond to locations ofDH5a: colonies.
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Figure 16: Figure showing hybridization of 32p -labeled 750bp PCR-RACE product to colony lifts oftransforrned
DH5cx cells containing recombinant pUC 19 plasmid. The dark spots indicated by arrows are areas of probe
hybridization to DH5cx colonies containing the PCR-RACE 750bp product. Spots not indicated by arrows are points
of false hybridization which do not cOlTespond to locations of DH5cx colonies.
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Figure 17: Figure shovving hybridization of 32p - labeled 500bp PCR-RACE product to colony lifts of transfonned
DH5cx cells containing recombinant pUC 19 plasmid. The dark spots indicated by arrows are areas of probe
hybridization to DH5cx colonies containing the PCR-RACE 500bp product. Spots not indicated by arrows are points
of false hybridization vvhich do not cOlTespond to locations ofDH5cx colonies.
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Figure 18: Figure sho\tving hybridization of 32p -labeled 450bp PCR-RACE product to colony lifts oftransfonned
DH5cx cells containing recombinant pUC 19 plasn1id. The dark spots indicated by arrows are areas of probe
hybridization to DH5cx colonies containing the PCR-RACE 450bp product. Spots not indicated by alTo\tvs are points
offalse hybridization which do not correspond to locations ofDH5cx colonies.
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Figure 19: Figure showing hybriditation Of 32p -labeled 200bp PCR-RACE product to colony lifts oftransfonned
DH5a cells containing recombinant pUC 19 plasmid. The dark spots indicated by alTOWS are areas of probe
hybridization to DH5a colonies containing the PCR-RACE 200bp product. Spots not indicated by arrows are points
offalse hybridization vvhich do not correspond to locations ofDH5a colonies.
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A
DNA sequence 153 b.p. aatcataggacc tattgccttaag linear
B
I 10 I 20 I 30 I 40 I 50 I 60
1 aatcatagga ccttggacta ctatcctact acgagtagct actctgcttc cttcgtctct 60
61 cttctcttgc ttctctctct acttctctct tcttcgttat agtcttttat gcaataatgg 120
121 gtgggtggtt gaccaaattg ttattgcctt aag 153
I 10 I 20 I 30 40 50 60
DNA sequence 166 b.p. AGAATCGCAACG AGGACTAGGAAT linear
I 10 I 20 I 30
1 AGAATCGCAA CGTCATGTCA TGTTAAGAGC
'61 GAAGAAGTTA GTTTTCATGT GTCCGTTACA
121 ATAGCGAAAT AGAATGGATG CGTCATTTGT
I 10 I 20 I 30
I 40 50 I 60
GAACTTACAT GTTCATGGTT AAGAAATAAC 60
TACCTAGTAA ATAGGTCAAG ATGTAGAGTC 120
TATTAGGACT AGGAAT 166
I 40 I 50 60
Figure 20: This figure depicts the 153bp 5' end mRNA sequence for the 200bp, 450bp, and 1500bp sequences (A),
and the166bp 3' end mRNA sequence for the 200bp, 450bp, and 1500bp sequences (B).
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Partial DNA sequences were obtained which correspond to the 5' and 3' ends of the 200bp,
450bp, and 1500bp sequences (Figure 20). DNA sequence comparisons to known sequences was
performed using the Fasta Server program (Pearson and Lipman, 1988). No significant DNA
sequence matches were obtained, and no homology to known FaRP-encoding sequences was
detected. Instead, the 153bp partial sequence corresponding to the degenerate oligonucleotide-
primed end of the sequence was found to possess 69.0% identity in a 58 bp overlap to the
Caenorhabditis elegans cosmid K09A11 which encodes for the cytochrome P450 gene, the
Transfer-RNA gene, the transposase gene and the tRNA-Tyr gene (Figure 21).
Sequence determination of the 500bp and 750bp amplification products indicated that
these products possessed identical sequences at their 3' and 5' ends.
The sequence amplified by the NFLRF(G)-encoding degenerate oligonucleotide primer
was AATCATAGGACCTTGAC, with 9 of the 17 bases matching those found in the primer
sequences (bases identical to those found in the degenerate oligonucleotide sequence are marked
in bold type). This amplified sequence does not encode for a FaRP sequence.
The NOT1 Adaptor-primer was also observed to bind non-specifically. The amplified
sequence primed by the NOT1 primer was ATATCCGCAGGTTTAACCACAAAATATA, with
16 of the 28 bases matching those found in the primer sequence.
Partial DNA sequences were obtained which correspond to the 5' and 3' ends of the 500bp
and 750bp sequences (Figure 22). Comparison of the amplified sequences to known gene
sequences, as performed using the Fasta Server program (Pearson and Lipman, 1988) did not
detect any homology to kn~wn FaRP-encoding sequences. No significant DNA sequence
matches were obtained. That sequence with the highest homology to the 5' end of the mRNA
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sequence was detennined to be the complete genome of the Vaccinia virus. The two sequences
possess 66.0% identity in a 50bp overlap (Figure 23).
The generated partial sequences were translated in 3 phases using the Strider program to
obtain the corresponding protein sequences. The longest available sequence in each phase, as
detennined by stop codon position, was examined for similarity to known protein sequences using
the Blitz program. No significant protein matches were obtained.
SCORES Initl: 56 Initn: 175 Opt: 75
69.0% identity in 58 bp overla~
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20 30 40 50 60 70
2041d1 CTGACCTCTACTATCCTACTACGAGTAGCTACTCTGCTTCCTTCGTCTCTCCTTCTCTTG
IIII1 I II 1I11 I I III III L
Cek09a CATGTAAGCGTGGACAAAATTTTCAGGTTCACTCTCC--CCATCGTAT-TTTTTCACTTG
4470 4480 4490 4500 4510 4520
80 90 100 110 120 130
2041d1 CTTCTCTCTCTACTTCTTCTTCGTTATAGTCTTTTATGCAATAATAATGGGTGGGTGGTT
I I I1111111111111 II I
Cek09a C GTAGCTACTTCTTCTTCGATAAATGTATGGTACTGAAAATCTCACTCAATTTCTA
4530 4540 4550 4560 4570 4580
Figure 21: This figure shows the results of the comparison of received amplification product sequences to known
sequences by means of the E:tv1BL Fasta Server in Heidelberg, Germany. The amplified sequence submitted for
comparison "vas a 153bp partial sequence corresponding to that region primed by the degenerate NFLRF(G)
oligonucleotide primer. This 153bp'partial sequence was identical for the 200bp, 450bp, and 1500bp amplification
products. The known sequence with the greatest homology to this 153bp sequence is the Caenorhabditis elegans
cosmid K09A11, which contains the genes for cytochrome P450, transfer-RNA, transposase, and tRNA-Tyr. As shown
in this figure, the cosmid has 69.0% identity in a 58bp overlap with the sequence of interest.
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A
DNA sequence 158 b.p. aatcataggacc tagaggtgctac· linear
B
I 10 I 20 I 30 I 40 I 50 I 60
1 aatcatagga ccttggacac tgcttaagca attaacattg tgcacacaga catatatatg 60
61 cataaagact ataagaagaa gaagtagaga gagaaagcga agagagaaga ggaagcagaa 120
121 gcgagatagc tactctgagt gatatgtaga ggtgctac 158
I 10 I 20 I 30 I 40 50 60
DNA sequence 165 b.p. ATATCCGCAGGT ATAGTAGAGGAG linear
10 I 20 I 30 I 40 I 50 I 60
1 ATATCCGCAG GTTTAACCAC AAAATATACT TAGGCAATAA CCAATTTGGC AAAACCACCA 60
61 TATTATGCAT AAAGCTATAC TGAAGAAGAA GTAGAGAGAG AAGCGAAGAG AAGGAGAAGA 120
121 CGAAGAGAAA GCAGAGATAG CTACTGCTAG TGGATAGTAG AGGAG 165
I 10 I 20 I 30 I 40 I 50 60
F~gure22: This figure depicts the 158bp 5' end mRNA sequence for the 500bp and 750bp sequences (A), and the165bp
3 end mRNA sequence for the 500bp and 450bp sequences (B).
SCORES Init1: 58 Initn: 152 Opt: 81
66.0% identity in 50 bp overlap
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80 90 100 110 120 130
24a004 TATAAGAAGAAGAAGTAGAGAGAGAAAGCGAAGAGAGAAGAGGAAGCAGAAGCGAGATAG
I II 11II II I I IIIII11 I
Pxvacc AAAATTATAATGAATA'M'ATTATGATGATTATGATAGAACTGGTATGAACAGCGAGAGCG
17953
140 150 160
24a004 CTACTCTGAGTGATAGTAGAGGTGCTAC
II I I (11111 ( II I
Pxvacc ATAGTGAGAGTGATAATATATCAATCAAAACAGAATATGAGAATGAATATGAATTCTATG
17959
Figure 23: This figure shows the results of the comparison of received amplification product sequences to known
sequences by means of the E~L Fasta Server in Heidelberg, Germany. The amplified sequence submitted for
comparison was 158bp partial sequence corresponding to that region primed by the degenerate NFLRF(G)
oligonucleotide primer. This 158bp partial sequence was identical for the 500bp and 750bp amplification products.
The known sequence with the greatest homology to this 158bp sequence is the complete genome of the Vaccinia virus.
As shown in this figure, the virus has 66.0% identity in a 50bp overlap with the sequence of interest.
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DISCUSSION
In this study, PCR-RACE reactions were optimized for the amplification ofProcambarlls
clarkii cDNA sequences with a degenerate oligonucleotide primer designed to recognize the two
sequenced Procambarus FaRPs. Reactions conditions including buffer composition, primers
used, cycle number, nature ofthe amplification substrate, annealing, extension, and denaturation
temperatures and times, and the use of re-amplification procedures, were varied and optimized.
The lack of observeable product in PCR reactions in which buffer did not contain 0.1%
gelatin may be accounted for, as the use of gelatin in PCR reactions is reported to improve
enzyme binding (Innis et aI., 1988). Without efficient enzyme binding, new strand synthesis is
impaired, resulting in reduced amounts of amplification product.
Although the addition of 10% glycerol to PCR buffer has been reported to maximize
efficient specific amplification (Li and Negre, 1993), its presence in test reactions was observed
to have little positive effect or a largely negative effect upon the quantity ofPCR-RACE product
received. It is unknown why these observations were received, as the exact role of glycerol in
peR reactions is unclear (Li and Negre, 1993).
Although PCR annealing temperatures are generally reccommended to be 2-4°C below
the lowest Tm of the primers, ann~aling performed at 42°C (4°C below the lowest k of the
primers) was found not to produce any observeable product. This lack of observeable product
may be accounted for by low primer annealing stringency at lower temperatures. With lowered
stringency, many different sequences with little homology to the primers may be recognized and
amplified to a low degree, obstructing consistant amplification of specific sequences with a high
degree of homology to the primers.
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The observation of products of much larger length in PCR-RACE re-amplification
reactions as compared to products in initial amplification reactions may be accounted for. PCR-
RACE reactions preferentially amplify shorter sequences (Frohman et aI., 1988). With re-
amplification, longer, underrepresented sequences may appear due to further amplification cycles.
Re-amplification was performed upon samples instead of simply increasing the number of
amplification cycles in initial PCR-RACE reactions, as product formation may be impaired due
to depletion of reaction constituents.
In the determination of insert presence in pUC 19 plasmid (Figure 14), the Pvu II and
EcoR! restriction endonucleases showed incomplete plasmid digestion. This may be accounted
for by an excess of salts in the reaction mixture, which impairs enzyme activity.
Generated PCR-RACE amplification products were studied to determine if they encoded
FaRP sequences. Although the 200bp, 450bp, and 1500bp sequences were found to have
homology to the Caenorhabditis elegans cosmid K09A11, and the 500bp and 750bp sequences
to have homology with the complete genome ofthe Vaccinia virus, in both cases these similarities
were deemed to be fortuitous due to the low identity percentages (69% and 66% respectively)
over short sequence overlaps (58bp and 50bp respectively). Although amplification products of
five different lengths were studied, only two different sequences were recognized and bound by
the degenerate oligonucleotide primer, while the NOT1 adaptor-primer was observed to recognze
and bind to two sequences which were not poly (A) sequences. The 200bp, 450bp, and 1500bp
sequences possess identical 3' and 5' sequences, and the 500bp and 750bp sequences also possess
3' and 5' sequences identical to each other. The absence of any known gene sequences in
Procambanls prevents identification of these isolated sequences. They are however, postulated
to be repeated sets of sequences found along Procambarlls mRNA. The presence of multiple
119
copies of highly similar sequences would encourage binding of the two primers, while the
tendancy ofpeR to amplify shorter fragments (Frohman et aI., 1988) may have contributed to
the binding of the NOT1 adaptor-primer to sequences internal to the poly (A) tail. The low
stringency of the NOT1 adaptor-primer binding may also be attributed to the 74°C melting
temperature (TnJ of this molecule being markedly higher than the 44°C annealing temperature
used in the PCR-RACE reactions.
The low stringency of the degenerate oligonucleotide primer may be due to several
factors. The use ofthe 16 different sequences togethor as a "mixed" primer neccesitated the use
ofan annealing temperature below the lowest Tm of the 16 different sequences. Thus, sequences
with TmS up to 8°C above the used annealing temperature may bind with low stringency to non-
FaRP sequences. If these sequences are shorter than, or in greater copy number than FaRP-
encoding sequences present, they may be preferentially amplified. Additional stringency problems
may be encountered with the use of cDNA enrichment procedures. Sequences recognized and
amplified at lowered annealing temperatures may continue to be amplified at raised temperatures
if they are similar to sequences of primers annealing well below their TmS.
Although the determination of primer sequences based upon Drosophila FaRP codon
usage was successfully used by Baro et al.(1993) in lobster, and this procedure was necessary due
to the absence of any sequenced Malacostracean genes, the determination of primer sequences
based uponDrosophilaFaRP codon usage may also be a factor in the amplification of unwanted
sequences. If Procambarus FaRP codon usage differs from that of Drosophila, then the
synthesized primers may not recognize encoded FaRP sequences. Finally, the use of a 17bp
oligonucleotide primer, which is ofminimal length for a primer, reduces the specificity of binding.
Although this primer was specifically designed so as to recognize both NFl and DF2, as well as
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any other possible NFLRF(Gly)-type sequences present, an increased primer length and sequence
designed to recognize either NFl or DF2 would be expected to yield amplification products of
greater specificity.
!he failure to receive inserts from the selected dscDNA library despite the consistently
white colour ofcolonies during blue/white selection (indicative ofvector recombination), may be
explained by short adaptor insertion into the i\gtll vector, or by base pair insertion or deletion
during ligation, at which time the vector is most succeptible to these reactions.
A failure to insert sequences into the Agt11 vector may be due simply to extremely low
amounts of dscDNA produced by degenerate oligonucleotide priming.
Possible future investigations to determine FaRP gene sequences using oligonucleotide
primers may benefit from the use ofthe SchistoFLRFamide (pDVDHVFLRFamide) primer/probe
received courtesy of Dr. Bill Bendena (Queens University, Kingston, ON), which should
recognize the encoded Procambarus FaRP pEXXDHVFLRFamide (where "X" indicates an
unide~tified amino acid). In further investigations it is recommended that a longer oligonucleotide
primer of lower degeneracy be used, if possible, so as to specifically bind to FaRP-encoding
sequences.
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SUMMARY
1. The PCR-RACE procedure was optimized for the degenerate oligonucleotide primer.
2. Re-amplification was important in PCR-RACE procedures.
3. Five PCR-RACE amplification products were sequenced.
4. The PCR-RACE amplification products were detennined not to be FaRP-encoding sequences.
5. The degenerate oligonucleotide;primer was observed to bind non-specifically.
6. It is unlikely that a selected cDNA library was successfully created.
7. Alternative strategies may be more useful in isolation ofFaRP-encoding gene sequences.
\ .
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